<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id><journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id><journal-id journal-id-type="publisher-id">hmg</journal-id><journal-id journal-id-type="hwp">hmg</journal-id><journal-title-group><journal-title>Human Molecular Genetics</journal-title></journal-title-group><issn pub-type="ppub">0964-6906</issn><issn pub-type="epub">1460-2083</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4240194</article-id><article-id pub-id-type="doi">10.1093/hmg/ddu359</article-id><article-id pub-id-type="publisher-id">ddu359</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title><italic>TCF7L2</italic> is a master regulator of insulin production and processing</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Yuedan</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Soo-Young</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bailey</surname><given-names>Kathleen</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ottosson-Laakso</surname><given-names>Emilia</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shcherbina</surname><given-names>Liliya</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Oskolkov</surname><given-names>Nikolay</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Enming</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Thevenin</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fadista</surname><given-names>Jo&#x000e3;o</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bennet</surname><given-names>Hedvig</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Vikman</surname><given-names>Petter</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wierup</surname><given-names>Nils</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fex</surname><given-names>Malin</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rung</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="af5">5</xref></contrib><contrib contrib-type="author"><name><surname>Wollheim</surname><given-names>Claes</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Nobrega</surname><given-names>Marcelo</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Renstr&#x000f6;m</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Groop</surname><given-names>Leif</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hansson</surname><given-names>Ola</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="af1"><label>1</label><addr-line>Department of Clinical Sciences</addr-line>, <institution>CRC, Lund University</institution>, <addr-line>Malm&#x000f6; 20502</addr-line>, <country>Sweden</country>,</aff><aff id="af2"><label>2</label><addr-line>Department of Medicine</addr-line> and</aff><aff id="af3"><label>3</label><addr-line>Department of Human Genetics</addr-line>, <institution>University of Chicago</institution>, <addr-line>IL 60637</addr-line>, <country>USA</country>,</aff><aff id="af4"><label>4</label><institution>European Bioinformatics Institute, Functional Genomics</institution>, <addr-line>Hinxton, Cambridge CB10 1SD</addr-line>, <country>UK</country>,</aff><aff id="af5"><label>5</label><addr-line>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory</addr-line>, <institution>Uppsala University</institution>, <addr-line>Uppsala 75185</addr-line>, <country>Sweden</country> and</aff><aff id="af6"><label>6</label><addr-line>Department of Cell Physiology and Metabolism</addr-line>, <institution>Universit&#x000e9; de Gen&#x000e8;ve, University Medical Centre</institution>, <addr-line>1 rue Michel-Servet, Geneva 4 1211</addr-line>, <country>Switzerland</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>To whom correspondence should be addressed at: Department of Clinical Science, Endocrinology and Diabetes, Lund University, Ing 72, Building 91, Fl 12, Sweden. Tel: +<phone>46-391228</phone>; Fax: +<fax>46-391222</fax>; Email: <email>Ola.Hansson@med.lu.se</email></corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>12</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>11</day><month>7</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>7</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the							<pub-date pub-type="epub"/>. --><volume>23</volume><issue>24</issue><fpage>6419</fpage><lpage>6431</lpage><history><date date-type="received"><day>29</day><month>4</month><year>2014</year></date><date date-type="rev-recd"><day>30</day><month>6</month><year>2014</year></date><date date-type="accepted"><day>7</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2014. Published by Oxford University Press.</copyright-statement><copyright-year>2014</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="ddu359.pdf"/><abstract><p>Genome-wide association studies have revealed &#x0003e;60 loci associated with type 2 diabetes (T2D), but the underlying causal variants and functional mechanisms remain largely elusive. Although variants in <italic>TCF7L2</italic> confer the strongest risk of T2D among common variants by presumed effects on islet function, the molecular mechanisms are not yet well understood. Using RNA-sequencing, we have identified a TCF7L2-regulated transcriptional network responsible for its effect on insulin secretion in rodent and human pancreatic islets. <italic>ISL1</italic> is a primary target of TCF7L2 and regulates proinsulin production and processing via <italic>MAFA</italic>, <italic>PDX1</italic>, <italic>NKX6.1</italic>, <italic>PCSK1</italic>, <italic>PCSK2</italic> and <italic>SLC30A8</italic>, thereby providing evidence for a coordinated regulation of insulin production and processing. The risk T-allele of rs7903146 was associated with increased <italic>TCF7L2</italic> expression, and decreased insulin content and secretion. Using gene expression profiles of 66 human pancreatic islets donors&#x02019;, we also show that the identified TCF7L2-ISL1 transcriptional network is regulated in a genotype-dependent manner. Taken together, these results demonstrate that not only synthesis of proinsulin is regulated by TCF7L2 but also processing and possibly clearance of proinsulin and insulin. These multiple targets in key pathways may explain why <italic>TCF7L2</italic> has emerged as the gene showing one of the strongest associations with T2D.</p></abstract></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p><italic>TCF7L2</italic> harbors common genetic variants with the strongest effect on type 2 diabetes (T2D) risk yet described, i.e. the single-nucleotide polymorphism (SNP rs7903146) (<xref rid="DDU359C1" ref-type="bibr">1</xref>&#x02013;<xref rid="DDU359C3" ref-type="bibr">3</xref>). TCF7L2 is a transcription factor (TF) in the Wnt-signaling pathway and expressed in many tissues including fat, liver and pancreatic islets of Langerhans (<xref rid="DDU359C4" ref-type="bibr">4</xref>). A majority of risk variants associated with T2D by GWAS seem to affect islet function (<xref rid="DDU359C5" ref-type="bibr">5</xref>,<xref rid="DDU359C6" ref-type="bibr">6</xref>). In concordance, the risk T-allele of rs7903146 is associated with impaired glucose-stimulated insulin secretion (GSIS) or other secretagogues-like GLP-1 (<xref rid="DDU359C2" ref-type="bibr">2</xref>,<xref rid="DDU359C7" ref-type="bibr">7</xref>&#x02013;<xref rid="DDU359C12" ref-type="bibr">12</xref>). Risk T-allele carriers are further characterized by an elevated plasma proinsulin level and an increased proinsulin-to-insulin ratio suggestive of perturbed proinsulin processing (<xref rid="DDU359C13" ref-type="bibr">13</xref>&#x02013;<xref rid="DDU359C21" ref-type="bibr">21</xref>). In support of a primary effect in pancreatic islets, the risk T-allele carriers show higher degree of open chromatin in pancreatic islets, but not in other tissues (<xref rid="DDU359C22" ref-type="bibr">22</xref>). Several mouse models of <italic>Tcf7l2</italic> have been investigated (<xref rid="DDU359C23" ref-type="bibr">23</xref>&#x02013;<xref rid="DDU359C28" ref-type="bibr">28</xref>), but the diabetic phenotype has not been replicated in all studies. Experiments in rodent islets where TCF7L2 activity has been disrupted have usually demonstrated impaired GSIS (<xref rid="DDU359C11" ref-type="bibr">11</xref>,<xref rid="DDU359C29" ref-type="bibr">29</xref>,<xref rid="DDU359C30" ref-type="bibr">30</xref>).</p><p>Paradoxically, carriers of the risk T-allele show increased expression of <italic>TCF7L2</italic> in human pancreatic islets (<xref rid="DDU359C7" ref-type="bibr">7</xref>,<xref rid="DDU359C31" ref-type="bibr">31</xref>). Plasmid construct carrying the risk T-allele, when compared with those with the C-allele, displayed a much stronger transcriptional activity, implying a higher enhancer activity of the T-allele (<xref rid="DDU359C22" ref-type="bibr">22</xref>,<xref rid="DDU359C32" ref-type="bibr">32</xref>). TCF7L2 may act both as a stimulator and a repressor of gene expression due to both differential splicing and interaction with different co-regulators in target gene recognition (<xref rid="DDU359C33" ref-type="bibr">33</xref>). However, the target genes of TCF7L2 in pancreatic islets or B-cells have not been described in detail. Our aim was to identify TCF7L2-target genes in pancreatic islets and to describe the regulatory network downstream of <italic>TCF7L2</italic> responsible for its influence on insulin secretion.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2a"><title><italic>Tcf7l2</italic> influences insulin synthesis and secretion</title><p>Impaired <italic>in vivo</italic> (<xref rid="DDU359C7" ref-type="bibr">7</xref>) and <italic>in vitro</italic> (<xref rid="DDU359C9" ref-type="bibr">9</xref>,<xref rid="DDU359C31" ref-type="bibr">31</xref>) insulin secretion has been shown in risk T-allele carriers of rs7903146. We have replicated and extended these findings in pancreatic islets from human non-diabetic cadaver donors (<italic>n</italic> = 75, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>A; <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S3</ext-link>). We also show reduced insulin content (27%) in risk T-allele carriers (<italic>n</italic> = 81, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>B), and that <italic>TCF7L2</italic> mRNA expression is 16% higher than C-allele carriers (<italic>n</italic> = 66; RNA-seq, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>C). Further, <italic>TCF7L2</italic> expression is negatively associated with proinsulin expression in human islets in C-allele carriers (<italic>n</italic> = 36), but not in T-allele carriers (<italic>n</italic> = 30, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>D; <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S3</ext-link>).
<fig id="DDU359F1" position="float"><label>Figure&#x000a0;1.</label><caption><p>The type 2 diabetes-associated SNP rs7903146 and <italic>TCF7L2</italic> expression influences insulin synthesis and secretion. (<bold>A</bold>) GSIS in human islets (CC: <italic>n</italic> = 44, CT/TT: <italic>n</italic> = 31). (<bold>B</bold>) Insulin content in human islets (CC: <italic>n</italic> = 45, CT/TT: <italic>n</italic> = 36). (<bold>C</bold>) <italic>TCF7L2</italic> mRNA expression measured by RNA-seq in human islets (CC: <italic>n</italic> = 36, CT/TT: <italic>n</italic> = 30). (<bold>D</bold>) Expression (mRNA) of <italic>INS</italic> and <italic>TCF7L2</italic> in human islets measured by RNA-seq stratified for rs7903146 genotype (CC: <italic>n</italic> = 36, CT/TT: <italic>n</italic> = 30). (<bold>E</bold>) GSIS in INS1 cells after <italic>Tcf7l2</italic> silencing. (<bold>F</bold>) GSPS in INS1 cells after <italic>Tcf7l2</italic> silencing. (<bold>G</bold>) Proinsulin-to-insulin ratio in INS1 cells after <italic>Tcf7l2</italic> silencing. (<bold>H</bold>) IHC staining of insulin and VAMP2 in INS1 cells after <italic>Tcf7l2</italic> silencing. (<bold>I</bold>) Amount of insulin-containing granules measured by TIRF microscopy in INS1 cells after <italic>Tcf7l2</italic> silencing. Data are represented as mean &#x000b1; SEM. In (A)&#x02013;(D), data were analyzed by linear regression with correction for age, gender and BMI. In (E)&#x02013;(I), 2.8 versus 16.7 m<sc>m</sc> glucose were analyzed by paired Student's <italic>t</italic>-tests, <italic>Tcf7l2</italic> silencing versus controls by unpaired Student's <italic>t</italic>-tests with <italic>n</italic> = 3. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01 and ***<italic>P</italic> &#x0003c; 0.001 (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Tables S1 and S4</ext-link>).</p></caption><graphic xlink:href="ddu35901"/></fig></p><p>Silencing <italic>Tcf7l2</italic> in a rat insulinoma cell line (INS1 832/13) using siRNA targeting the invariable exon 1, resulted in 84% knockdown of <italic>Tcf7l2</italic> mRNA, 90% reduction of TCF7L2 activity and a reduced expression of the well-known TCF7L2-target genes <italic>Axin2</italic> and <italic>Ccnd1</italic> (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Fig. S1</ext-link>A and B) (<xref rid="DDU359C30" ref-type="bibr">30</xref>). The decrease in <italic>Tcf7l2</italic> resulted in a marked reduction of GSIS, i.e. 1.76-fold (<italic>Tcf7l2</italic> silencing, <italic>P</italic> &#x0003e; 0.05) versus 6.97-fold (controls, <italic>P</italic> &#x0003c; 0.05, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>E) and a perturbed glucose-stimulated proinsulin secretion (GSPS) (<italic>P</italic> &#x0003c; 0.05, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>F). Proinsulin-to-insulin ratio was higher under glucose stimulation compared with basal condition in <italic>Tcf7l2</italic> silenced cells (<italic>P</italic> &#x0003c; 0.05, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>G) suggesting perturbed proinsulin processing. Immunohistochemistry (IHC) analysis of <italic>Tcf7l2</italic> silenced INS1 cells showed reduced staining intensity for insulin (<italic>P</italic> &#x0003c; 0.001) and VAMP2 (<italic>P</italic> &#x0003c; 0.001), a marker of insulin-containing granules, in <italic>Tcf7l2</italic> silenced cells (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>H). Furthermore, there was a reduction in insulin-containing granules close to the plasma membrane as assessed by total internal reflection fluorescence (TIRF) microscopy (<italic>P</italic> &#x0003c; 0.05, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>I). Together, these data suggest that TCF7L2 mediates key aspects of insulin production, processing and intracellular trafficking.</p></sec><sec id="s2b"><title>Identification of TCF7L2-target genes influencing insulin synthesis and secretion</title><p>The molecular mechanisms underlying these findings are not clear, but an altered expression of TCF7L2-target genes is likely part of the explanation. To identify genes regulated by TCF7L2 in B-cells, we screened for global differential expression using RNA-seq in <italic>Tcf7l2</italic> silenced INS1 cells versus scramble-treated control. Overall, 10779 genes were actively expressed (&#x0003e;30 aligned paired-end reads per gene, corresponding to &#x0003e;&#x0223c;10 FPKM); 1680 genes were upregulated and 1885 genes were downregulated in <italic>Tcf7l2</italic> silenced cells (5% false discovery rate, FDR, <italic>n</italic> = 4). Among the most differentially expressed genes were <italic>Il6r</italic>, <italic>Aldh1a1</italic> and <italic>Srp14</italic>, but none of these has a known function in insulin secretion. Genetic variation in the <italic>IL6R</italic>-locus has been weakly associated with T2D (<xref rid="DDU359C34" ref-type="bibr">34</xref>), but this was not replicated (<xref rid="DDU359C35" ref-type="bibr">35</xref>) or supported by recent GWAS findings (<xref rid="DDU359C21" ref-type="bibr">21</xref>,<xref rid="DDU359C36" ref-type="bibr">36</xref>&#x02013;<xref rid="DDU359C42" ref-type="bibr">42</xref>); therefore, <italic>Il6r</italic> was not studied further. Instead we categorized genes known to influence GSIS into three groups: (i) glucose sensing, (ii) proinsulin expression and maturation and (iii) exocytotic machinery (genes differentially regulated in the RNAseq screen are reported in Table&#x000a0;<xref ref-type="table" rid="DDU359TB1">1</xref>). In addition, genes located proximal to SNPs with replicated associations to T2D and/or plasma proinsulin were also selected for further analysis (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S2</ext-link>). Real-time quantitative PCR (QPCR) confirmed the RNA-seq results for many of the tested genes (Table&#x000a0;<xref ref-type="table" rid="DDU359TB1">1</xref>), i.e. 18 out of 29 analyzed genes were replicated in independent samples at the mRNA level. To confirm these findings at the protein level, a selected set of 15 genes (with mRNA change &#x0003e;30%) was analyzed using western blot, with 11 genes having significant changes (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S3</ext-link>, the complete list of 3565 potential target gene can be found in the <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S6</ext-link>).
<table-wrap id="DDU359TB1" position="float"><label>Table&#x000a0;1.</label><caption><p>mRNA expression of selected genes influencing GSIS measured using RNA sequencing (RNAseq) in <italic>Tcf7l2</italic> depleted INS1 832/13 cells versus scrambled control, with replication in independent experiments using real-time QPCR</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" rowspan="2" colspan="1">Gene symbol</th><th align="left" rowspan="2" colspan="1">Gene ID</th><th align="center" colspan="2" rowspan="1">RNAseq<hr/></th><th align="center" colspan="2" rowspan="1">QPCR<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">LogFC</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value corrected</th><th align="left" rowspan="1" colspan="1">LogFC</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td rowspan="5" colspan="1">Glucose sensing</td><td rowspan="1" colspan="1"><italic>Glud1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000010222</td><td rowspan="1" colspan="1">&#x02212;0.7143</td><td rowspan="1" colspan="1">7.15E&#x02212;07</td><td rowspan="1" colspan="1">&#x02212;0.8681</td><td rowspan="1" colspan="1">4.97E&#x02212;03</td></tr><tr><td rowspan="1" colspan="1"><italic>Slc2a2</italic></td><td rowspan="1" colspan="1">ENSRNOG00000011875</td><td rowspan="1" colspan="1">&#x02212;0.5864</td><td rowspan="1" colspan="1">9.20E&#x02212;06</td><td rowspan="1" colspan="1">&#x02212;0.4150</td><td rowspan="1" colspan="1">2.68E&#x02212;03</td></tr><tr><td rowspan="1" colspan="1"><italic>Gck</italic></td><td rowspan="1" colspan="1">ENSRNOG00000015024</td><td rowspan="1" colspan="1">&#x02212;1.1232</td><td rowspan="1" colspan="1">6.26E&#x02212;04</td><td rowspan="1" colspan="1">&#x02212;0.0145</td><td rowspan="1" colspan="1">0.9905</td></tr><tr><td rowspan="1" colspan="1"><italic>G6pc</italic></td><td rowspan="1" colspan="1">ENSRNOG00000036806</td><td rowspan="1" colspan="1">0.3828</td><td rowspan="1" colspan="1">7.80E&#x02212;04</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td></tr><tr><td rowspan="1" colspan="1"><italic>Mpc1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000012415</td><td rowspan="1" colspan="1">&#x02212;0.4338</td><td rowspan="1" colspan="1">2.00E&#x02212;03</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td></tr><tr><td rowspan="11" colspan="1">Exocytotic machinery</td><td rowspan="1" colspan="1"><italic>Cacna1a</italic></td><td rowspan="1" colspan="1">ENSRNOG00000002559</td><td rowspan="1" colspan="1">&#x02212;1.0612</td><td rowspan="1" colspan="1">2.71E&#x02212;12</td><td rowspan="1" colspan="1">&#x02212;1.5564</td><td rowspan="1" colspan="1">6.52E&#x02212;04</td></tr><tr><td rowspan="1" colspan="1"><italic>Syt5</italic></td><td rowspan="1" colspan="1">ENSRNOG00000018217</td><td rowspan="1" colspan="1">&#x02212;0.9024</td><td rowspan="1" colspan="1">2.46E&#x02212;10</td><td rowspan="1" colspan="1">&#x02212;0.4739</td><td rowspan="1" colspan="1">4.24E&#x02212;02</td></tr><tr><td rowspan="1" colspan="1"><italic>Stxbp1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000015420</td><td rowspan="1" colspan="1">&#x02212;0.6269</td><td rowspan="1" colspan="1">5.93E&#x02212;06</td><td rowspan="1" colspan="1">&#x02212;0.3401</td><td rowspan="1" colspan="1">4.51E&#x02212;02</td></tr><tr><td rowspan="1" colspan="1"><italic>Cacna1d</italic></td><td rowspan="1" colspan="1">ENSRNOG00000013147</td><td rowspan="1" colspan="1">&#x02212;0.6143</td><td rowspan="1" colspan="1">1.89E&#x02212;05</td><td rowspan="1" colspan="1">&#x02212;1.0893</td><td rowspan="1" colspan="1">1.88E&#x02212;02</td></tr><tr><td rowspan="1" colspan="1"><italic>Cacna1c</italic></td><td rowspan="1" colspan="1">ENSRNOG00000007090</td><td rowspan="1" colspan="1">&#x02212;0.7861</td><td rowspan="1" colspan="1">2.10E&#x02212;05</td><td rowspan="1" colspan="1">&#x02212;0.8625</td><td rowspan="1" colspan="1">2.20E&#x02212;03</td></tr><tr><td rowspan="1" colspan="1"><italic>Cacnb3</italic></td><td rowspan="1" colspan="1">ENSRNOG00000012489</td><td rowspan="1" colspan="1">&#x02212;0.5654</td><td rowspan="1" colspan="1">6.67E&#x02212;04</td><td rowspan="1" colspan="1">&#x02212;1.0000</td><td rowspan="1" colspan="1">4.00E&#x02212;04</td></tr><tr><td rowspan="1" colspan="1"><italic>Stx1a</italic></td><td rowspan="1" colspan="1">ENSRNOG00000029165</td><td rowspan="1" colspan="1">0.5308</td><td rowspan="1" colspan="1">5.10E&#x02212;04</td><td rowspan="1" colspan="1">&#x02212;0.0145</td><td rowspan="1" colspan="1">0.8288</td></tr><tr><td rowspan="1" colspan="1"><italic>Snap25</italic></td><td rowspan="1" colspan="1">ENSRNOG00000006037</td><td rowspan="1" colspan="1">&#x02212;0.4135</td><td rowspan="1" colspan="1">3.49E&#x02212;03</td><td rowspan="1" colspan="1">&#x02212;0.2863</td><td rowspan="1" colspan="1">0.2271</td></tr><tr><td rowspan="1" colspan="1"><italic>Syt9</italic></td><td rowspan="1" colspan="1">ENSRNOG00000019613</td><td rowspan="1" colspan="1">&#x02212;0.4048</td><td rowspan="1" colspan="1">1.28E&#x02212;02</td><td rowspan="1" colspan="1">&#x02212;0.3219</td><td rowspan="1" colspan="1">0.0597</td></tr><tr><td rowspan="1" colspan="1"><italic>Cacnb1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000004518</td><td rowspan="1" colspan="1">0.6164</td><td rowspan="1" colspan="1">2.76E&#x02212;02</td><td rowspan="1" colspan="1">&#x02212;0.0589</td><td rowspan="1" colspan="1">0.6316</td></tr><tr><td rowspan="1" colspan="1"><italic>Vamp2</italic></td><td rowspan="1" colspan="1">ENSRNOG00000006989</td><td rowspan="1" colspan="1">&#x02212;0.2960</td><td rowspan="1" colspan="1">3.29E&#x02212;02</td><td rowspan="1" colspan="1">&#x02212;0.2176</td><td rowspan="1" colspan="1">0.2964</td></tr><tr><td rowspan="13" colspan="1">Proinsulin production and maturation</td><td rowspan="1" colspan="1"><italic>Slc30a8</italic></td><td rowspan="1" colspan="1">ENSRNOG00000004747</td><td rowspan="1" colspan="1">&#x02212;1.4601</td><td rowspan="1" colspan="1">1.08E&#x02212;15</td><td rowspan="1" colspan="1">&#x02212;0.8365</td><td rowspan="1" colspan="1">8.80E&#x02212;03</td></tr><tr><td rowspan="1" colspan="1"><italic>NeuroD1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000005609</td><td rowspan="1" colspan="1">&#x02212;1.1931</td><td rowspan="1" colspan="1">9.73E&#x02212;14</td><td rowspan="1" colspan="1">&#x02212;1.2176</td><td rowspan="1" colspan="1">3.17E&#x02212;03</td></tr><tr><td rowspan="1" colspan="1"><italic>Cpe</italic></td><td rowspan="1" colspan="1">ENSRNOG00000043387</td><td rowspan="1" colspan="1">&#x02212;1.4682</td><td rowspan="1" colspan="1">3.16E&#x02212;09</td><td rowspan="1" colspan="1">&#x02212;0.3040</td><td rowspan="1" colspan="1">0.1358</td></tr><tr><td rowspan="1" colspan="1"><italic>Isl1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000012556</td><td rowspan="1" colspan="1">&#x02212;1.1075</td><td rowspan="1" colspan="1">1.23E&#x02212;07</td><td rowspan="1" colspan="1">&#x02212;1.3585</td><td rowspan="1" colspan="1">7.40E&#x02212;04</td></tr><tr><td rowspan="1" colspan="1"><italic>Ins1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000012052</td><td rowspan="1" colspan="1">&#x02212;1.1761</td><td rowspan="1" colspan="1">5.38E&#x02212;07</td><td rowspan="1" colspan="1">&#x02212;1.3959</td><td rowspan="1" colspan="1">1.40E&#x02212;02</td></tr><tr><td rowspan="1" colspan="1"><italic>Pcsk2</italic></td><td rowspan="1" colspan="1">ENSRNOG00000005438</td><td rowspan="1" colspan="1">&#x02212;0.8951</td><td rowspan="1" colspan="1">9.81E&#x02212;06</td><td rowspan="1" colspan="1">&#x02212;0.6897</td><td rowspan="1" colspan="1">4.56E&#x02212;02</td></tr><tr><td rowspan="1" colspan="1"><italic>Nkx6.1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000002149</td><td rowspan="1" colspan="1">&#x02212;0.6335</td><td rowspan="1" colspan="1">7.70E&#x02212;05</td><td rowspan="1" colspan="1">&#x02212;0.5995</td><td rowspan="1" colspan="1">9.26E&#x02212;04</td></tr><tr><td rowspan="1" colspan="1"><italic>Pcsk1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000011107</td><td rowspan="1" colspan="1">&#x02212;0.7932</td><td rowspan="1" colspan="1">8.45E&#x02212;05</td><td rowspan="1" colspan="1">&#x02212;0.7859</td><td rowspan="1" colspan="1">3.45E&#x02212;03</td></tr><tr><td rowspan="1" colspan="1"><italic>Nkx2.2</italic></td><td rowspan="1" colspan="1">ENSRNOG00000012728</td><td rowspan="1" colspan="1">&#x02212;1.0863</td><td rowspan="1" colspan="1">4.18E&#x02212;03</td><td rowspan="1" colspan="1">&#x02212;0.8021</td><td rowspan="1" colspan="1">2.30E&#x02212;02</td></tr><tr><td rowspan="1" colspan="1"><italic>Ins2</italic></td><td rowspan="1" colspan="1">ENSRNOG00000020405</td><td rowspan="1" colspan="1">&#x02212;0.9005</td><td rowspan="1" colspan="1">5.11E&#x02212;03</td><td rowspan="1" colspan="1">&#x02212;1.0893</td><td rowspan="1" colspan="1">1.35E&#x02212;02</td></tr><tr><td rowspan="1" colspan="1"><italic>MafA</italic></td><td rowspan="1" colspan="1">ENSRNOG00000007668</td><td rowspan="1" colspan="1">&#x02212;1.1927</td><td rowspan="1" colspan="1">4.61E&#x02212;02</td><td rowspan="1" colspan="1">&#x02212;2.1844</td><td rowspan="1" colspan="1">2.96E&#x02212;03</td></tr><tr><td rowspan="1" colspan="1"><italic>Pax4</italic></td><td rowspan="1" colspan="1">ENSRNOG00000008020</td><td rowspan="1" colspan="1">2.9857<sup>a</sup></td><td rowspan="1" colspan="1">4.75E&#x02212;02</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td></tr><tr><td rowspan="1" colspan="1"><italic>Pdx1</italic></td><td rowspan="1" colspan="1">ENSRNOG00000046458</td><td rowspan="1" colspan="1">N/A<sup>b</sup></td><td rowspan="1" colspan="1">N/A<sup>b</sup></td><td rowspan="1" colspan="1">&#x02212;0.8110</td><td rowspan="1" colspan="1">2.19E&#x02212;02</td></tr></tbody></table><table-wrap-foot><fn id="TN1"><p>N/A, not analyzed using QPCR; LogFC, the logarithm of fold change, i.e. <italic>Tcf7l2</italic> depleted/scrambled control; the <italic>P</italic>-value for RNAseq was corrected by FDR 5%. <italic>P</italic>-value for QPCR was calculated using Student's <italic>t</italic>-tests; <italic>N</italic> = 4 (RNAseq), <italic>N</italic> = 3 (QPCR).</p></fn><fn id="TN2"><p><sup>a</sup>Very low expression.</p></fn><fn id="TN3"><p><sup>b</sup><italic>Pdx1</italic> was not aligned in the RNA-seq analysis.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s2c"><title><italic>Tcf7l2</italic> is a key regulator of proinsulin production and processing</title><p>Twelve analyzed genes involved in proinsulin synthesis were downregulated in <italic>Tcf7l2</italic> silenced cells, including proinsulin genes <italic>Ins1</italic> and <italic>Ins2</italic> (Table&#x000a0;<xref ref-type="table" rid="DDU359TB1">1</xref> and Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>A). The reduction of all but one (<italic>Cpe</italic>) was confirmed using QPCR. The protein encoded by the <italic>Ins1</italic> and <italic>Ins2</italic> genes was decreased in <italic>Tcf7l2</italic> silenced cells (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>A). We next replicated this finding in primary cells by measuring proinsulin protein expression in a <italic>Tcf7l2</italic> homozygous null mouse model (<italic>Tcf7l2</italic><sup>&#x02212;/&#x02212;</sup>) (<xref rid="DDU359C26" ref-type="bibr">26</xref>). Notably, proinsulin expression was reduced by 85% (<italic>n</italic> = 6) in pancreas from <italic>Tcf7l2</italic><sup>&#x02212;/&#x02212;</sup> mice (postnatal day 0; P0) compared with wild-type mice (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>B). Given differences in the insulin gene between rodents and humans (<xref rid="DDU359C43" ref-type="bibr">43</xref>), we also replicated the findings in human pancreatic islets showing 49% reduced proinsulin mRNA expression after <italic>TCF7L2</italic> silencing (<italic>n</italic> = 5, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>C).
<fig id="DDU359F2" position="float"><label>Figure&#x000a0;2.</label><caption><p>TCF7L2 is a key regulator of proinsulin production and processing. (<bold>A</bold>) mRNA expression measured by QPCR in INS1 cells in <italic>Tcf7l2</italic> silenced versus control cells (<italic>n</italic> = 3). Protein expression measured by western blot in INS1 cells in <italic>Tcf7l2</italic> silenced versus control cells (<italic>n</italic> = 3). (<bold>B</bold>) Protein expression measured by western blot in <italic>Tcf7l2</italic> allele-null versus wild-type mice (<italic>n</italic> = 6). (<bold>C</bold>) mRNA expression measured by QPCR in human pancreatic islets in <italic>TCF7L2</italic> silenced versus control islets (<italic>n</italic> = 3&#x02013;5). Data are represented as mean &#x000b1; SEM. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01 and ***<italic>P</italic> &#x0003c; 0.001 analyzed by Student's <italic>t</italic>-tests (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S1</ext-link>).</p></caption><graphic xlink:href="ddu35902"/></fig></p><p>In the processing of proinsulin to insulin, the endoprotease prohormone convertase 1/3 (PCSK1) and prohormone convertase 2 (PCSK2) cleave the proinsulin molecule to yield mature insulin and C-peptide. We found reduced mRNA expression levels of both <italic>Pcsk1</italic> and <italic>Pcsk2</italic> in the RNA-seq screen of <italic>Tcf7l2</italic> silenced INS1 cells (Table&#x000a0;<xref ref-type="table" rid="DDU359TB1">1</xref>). This result was confirmed using QPCR and at the protein level in INS1 cells (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>A). No significant change in PCSK1 and PCSK2 protein expression was observed in the <italic>Tcf7l2</italic><sup>&#x02212;/&#x02212;</sup> mouse pancreas (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>B). In <italic>TCF7L2</italic> silenced human pancreatic islets, <italic>PCSK1</italic> and <italic>PCSK2</italic> mRNA expression was reduced by 36 and 49%, respectively (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>C).</p></sec><sec id="s2d"><title><italic>Tcf7l2</italic> is not a major regulator of genes involved in the exocytotic machinery or glucose sensing</title><p>Of the 11 genes categorized as involved in the exocytotic machinery, mRNA expression of <italic>Cacna1a</italic>, <italic>Cana1c</italic>, <italic>Cacna1d</italic> and <italic>Cacnb3</italic> was reduced in <italic>Tcf7l2</italic> silenced cells (Table&#x000a0;<xref ref-type="table" rid="DDU359TB1">1</xref>; <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Fig. S1</ext-link>C). However, this was not confirmed at the protein level for Cav2.1, Cav1.2 or Cav1.3, either 72 h or 7 days after <italic>Tcf7l2</italic> silencing (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Fig. S1</ext-link>D and E). RNA expression of two out of the five genes involved in glucose sensing (<italic>Glud1</italic> and <italic>Slc2a2/Glut2</italic>) was reduced at the mRNA level in <italic>Tcf7l2</italic> silenced cells (Table&#x000a0;<xref ref-type="table" rid="DDU359TB1">1</xref>), and GLUD1 protein expression was measured but no change was observed (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Fig. S1</ext-link>F).</p></sec><sec id="s2e"><title><italic>Tcf7l2</italic> is regulating proinsulin expression directly via Isl1, Ins1 and indirectly via <italic>MafA</italic>, <italic>NeuroD1</italic> and <italic>Pdx1</italic></title><p>After establishing that TCF7L2 is a regulator of proinsulin expression and maturation, we investigated by which molecular mechanism this may occur. For this purpose, we interrogated the RNA-seq results for genes differentially expressed between <italic>Tcf7l2</italic> silenced INS1 and control cells. Intriguingly, ISL LIM homeobox 1 (<italic>Isl1</italic>), v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A (<italic>MafA</italic>), pancreatic and duodenal homeobox 1 (<italic>Pdx1</italic>), neuronal differentiation 1 (<italic>NeuroD1</italic>), NK6 homeobox 1 (<italic>Nkx6.1</italic>) and NK2 homeobox 2 (<italic>Nkx2.2</italic>) were all expressed at lower levels in <italic>Tcf7l2</italic> silenced cells (Table&#x000a0;<xref ref-type="table" rid="DDU359TB1">1</xref>). All observations, except the NKX2.2 protein, were confirmed using QPCR and western blot (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F3">3</xref>A). The reduction of ISL1 and NEUROD1 was further confirmed using IHC (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Fig. S1</ext-link>G and H). These results were confirmed in <italic>Tcf7l2</italic><sup>&#x02212;/&#x02212;</sup> mice, with protein levels reduced relative to wild-type mice for ISL1, MAFA and NEUROD1 (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F3">3</xref>B). Likewise, after <italic>TCF7L2</italic> silencing in human islets, expression of most transcripts was downregulated, including <italic>ISL1</italic>, <italic>MAFA</italic>, <italic>PDX1</italic>, <italic>NEUROD1</italic> and <italic>NKX6.1</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F3">3</xref>C). In addition, in islets from CC-genotype carriers of rs7903146, <italic>TCF7L2</italic> mRNA expression was negatively associated with that of <italic>ISL1</italic>, <italic>MAFA</italic> and <italic>NKX6.1</italic> but not for <italic>MAFA</italic> and <italic>NKX6.1</italic> in CT/TT-risk-genotype carriers (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S4</ext-link>). The disruption of <italic>Tcf7l2</italic> resulted in a marked reduction in GSIS compared with controls 1.93- (<italic>P</italic> &#x0003e; 0.05) versus 4.10-fold (<italic>P</italic> &#x0003c; 0.05) increases (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F3">3</xref>D). The same was observed after disruption of <italic>Isl1</italic>, <italic>MafA</italic> and <italic>NeuroD1</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F3">3</xref>D).
<fig id="DDU359F3" position="float"><label>Figure&#x000a0;3.</label><caption><p>TCF7L2 is regulating proinsulin expression via direct regulation of ISL1 and indirectly via MAFA, NEUROD1 and PDX1. (<bold>A</bold>) mRNA expression measured by QPCR in INS1 cells in <italic>Tcf7l2</italic> silenced versus control cells, (<italic>n</italic> = 3). Protein expression measured by western blot in INS1 cells in <italic>Tcf7l2</italic> silenced versus control cells, (<italic>n</italic> = 3). (<bold>B</bold>) Protein expression measured by western blot in <italic>Tcf7l2</italic> allele-null versus wild-type mice (<italic>n</italic> = 6). (<bold>C</bold>) mRNA expression measured by QPCR in human pancreatic islets in <italic>Tcf7l2</italic> silenced versus control cells, (<italic>n</italic> = 3). (<bold>D</bold>) GSIS in INS1 cells after <italic>Tcf7l2</italic>, <italic>Isl1</italic>, <italic>MafA</italic> and <italic>NeuroD1</italic> silencing (<italic>n</italic> = 3). Data are represented as mean &#x000b1; SEM. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01 and ***<italic>P</italic> &#x0003c; 0.001 analyzed in (A)&#x02013;(C) by unpaired Student's <italic>t</italic>-tests. In (D), 2.8 versus 16.7 mM glucose were analyzed by paired Student's <italic>t</italic>-tests (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S1</ext-link>).</p></caption><graphic xlink:href="ddu35903"/></fig></p><p>To delineate the proinsulin regulatory cascade among the identified TCF7L2-target genes, <italic>Isl1</italic>, <italic>MafA</italic>, <italic>Pdx1</italic>, <italic>NeuroD1</italic> and <italic>Nkx6.1</italic> were sequentially silenced in INS1 cells using siRNA. First, knocking down <italic>Isl1</italic> reduced both the mRNA and protein expression of <italic>MafA</italic>, <italic>Pdx1</italic>, <italic>Nkx6.1</italic>, <italic>Pcsk1</italic>, <italic>Pcsk2</italic>, <italic>Ins1</italic> and <italic>Ins2</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>A). No effect of <italic>Isl1</italic> knockdown was observed on <italic>Tcf7l2</italic> or <italic>NeuroD1</italic> mRNA expression (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>A). Previously, we have analyzed chromatin immunoprecipitation on tiling array (ChIP-on-Chip) using a TCF7L2 antibody identifying both the <italic>Isl1</italic> and <italic>Ins1</italic> promoters as directly bound by TCF7L2 (<xref rid="DDU359C30" ref-type="bibr">30</xref>). Together, these data indicate that <italic>Isl1</italic> is a direct primary target gene for TCF7L2 and regulates proinsulin expression and processing via <italic>Isl1</italic>-dependent regulation of <italic>MafA</italic>, <italic>Pdx1</italic>, <italic>Nkx6.1</italic>, <italic>Pcsk1</italic> and <italic>Pcsk2</italic>. In human islets, <italic>ISL1</italic> expression is positively associated in C-allele carriers with that of <italic>MAFA</italic>, <italic>PDX1</italic>, <italic>NKX6.1</italic>, <italic>INS</italic> and <italic>SLC30A8</italic> but in T-allele carriers only with <italic>PDX1</italic> and <italic>NKX6.1</italic> (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S4</ext-link>).
<fig id="DDU359F4" position="float"><label>Figure&#x000a0;4.</label><caption><p>Sequential silencing of TCF7L2-target genes in the proinsulin regulatory cascade. mRNA and protein expression after: (<bold>A</bold>) <italic>Isl1</italic>, (<bold>B</bold>) <italic>MafA</italic>, (<bold>C</bold>) <italic>Pdx1</italic>, (<bold>D</bold>) <italic>NeuroD1</italic> and (<bold>E</bold>) <italic>Nkx6.1</italic> silencing versus controls measured by QPCR and western blot in INS1 cells. Data are represented as mean &#x000b1; SEM. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01 and ***<italic>P</italic> &#x0003c; 0.001 analyzed by Student's <italic>t</italic>-tests with <italic>n</italic> = 3 (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S1</ext-link>).</p></caption><graphic xlink:href="ddu35904A"/><graphic xlink:href="ddu35904B"/></fig></p><p>Knocking down <italic>MafA</italic> reduced mRNA expression of <italic>Nkx6.1</italic>, <italic>Nkx2.2</italic>, <italic>Pcsk2</italic>, <italic>Ins1</italic> and <italic>Ins2</italic>. These changes were confirmed at the protein level for all but NKX6.1 and NKX2.2 (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>B). In human islets, <italic>MAFA</italic> expression was positively associated with proinsulin gene expression both in C- and T-allele carriers (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S4</ext-link>)<italic>.</italic> Knocking down <italic>Pdx1</italic> reduced the mRNA expression of <italic>MafA</italic>, <italic>Nkx6.1</italic>, <italic>Nkx2.2</italic>, <italic>Pcsk2</italic>, <italic>Ins1</italic> and <italic>Ins2</italic>. These changes were confirmed at the protein level for all but PCSK2 (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>C). Knocking down <italic>NeuroD1</italic> reduced the mRNA expression of <italic>Tcf7l2</italic>, <italic>Isl1</italic>, <italic>MafA</italic>, <italic>Pdx1</italic>, <italic>Nkx6.1</italic>, <italic>Nkx2.2</italic>, <italic>Pcsk1</italic>, <italic>Pcsk2</italic>, <italic>Ins1</italic> and <italic>Ins2</italic>. This was, however, not reflected by changes in the ISL1, MAFA and PDX1 protein levels (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>D). Knocking down <italic>Nkx6.1</italic> reduced the mRNA expression of <italic>Tcf7l2</italic>, <italic>Isl1</italic>, <italic>MafA</italic>, <italic>Pdx1</italic>, <italic>Nkx6.1</italic>, <italic>Nkx2.2</italic>, <italic>Pcsk2</italic>, <italic>Ins1</italic> and <italic>Ins2</italic>. At the protein level, we could only confirm the reduction of MAFA and proinsulin (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>E).</p><p>In summary, these data together with previous ChIP-on-Chip results (<xref rid="DDU359C30" ref-type="bibr">30</xref>) indicate that ISL1 is a direct target of TCF7L2 and that ISL1, in turn regulates proinsulin production and processing via regulation of MAFA, PDX1, NKX6.1, PCSK1 and PCSK2 expression.</p></sec><sec id="s2f"><title>TCF7L2 is a transcriptional regulator of key genes located in T2D-associated loci</title><p>Next, we examined whether silencing of <italic>Tcf7l2</italic> was associated with changes in expression of rat orthologs of putative genes in T2D-associated loci (<xref rid="DDU359C36" ref-type="bibr">36</xref>,<xref rid="DDU359C37" ref-type="bibr">37</xref>,<xref rid="DDU359C41" ref-type="bibr">41</xref>,<xref rid="DDU359C44" ref-type="bibr">44</xref>&#x02013;<xref rid="DDU359C46" ref-type="bibr">46</xref>) (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S2</ext-link>). We observed differential mRNA expression for 23 genes, 17 out of these were replicated using QPCR and 3 at the protein level (i.e. <italic>Slc30a8</italic>, <italic>Ide</italic> and <italic>Bcl11a</italic>) (Figs&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref> and <xref ref-type="fig" rid="DDU359F5">5</xref>). Of note, <italic>Tcf7l2</italic> silencing in INS1 cells led to a decreased mRNA expression of <italic>Slc30a8</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>A). In pancreata from <italic>Tcf7l2</italic><sup>&#x02212;/&#x02212;</sup> mice, ZnT8 (<italic>Slc30a8</italic>) expression was reduced by 44% compared with wild-type control mice (<italic>n</italic> = 6, Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>B). This was also replicated in human islets showing a 46% reduction of <italic>SLC30A8</italic> mRNA expression after <italic>TCF7L2</italic> silencing (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>C). ZnT8 protein expression was also reduced in INS1 cells after <italic>Isl1</italic> and <italic>NeuroD1</italic> silencing (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>A and D), but not after <italic>Pdx1</italic>, <italic>MafA</italic> and <italic>Nkx6.1</italic> silencing (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F4">4</xref>B, C and E).
<fig id="DDU359F5" position="float"><label>Figure&#x000a0;5.</label><caption><p>TCF7L2 is a transcriptional regulator of key genes located in T2D-associated loci. mRNA expression measured by QPCR in INS1 cells in <italic>Tcf7l2</italic> silenced versus control cells, (<italic>n</italic> = 3). Protein expression was measured for two genes, i.e. IDE and BCL2, by western blot in INS1 cells in <italic>Tcf7l2</italic> silenced versus controls (<italic>n</italic> = 3). Data are represented as mean &#x000b1; SEM. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01 and ***<italic>P</italic> &#x0003c; 0.001 analyzed by Student's <italic>t</italic>-tests (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S1</ext-link>).</p></caption><graphic xlink:href="ddu35905"/></fig></p><p>Finally, expression (mRNA) of <italic>Grk5</italic>, <italic>Ide</italic>, <italic>Prox1</italic>, <italic>Kcnk16</italic>, <italic>Gipr</italic>, <italic>Adamts9</italic>, <italic>Srebf1</italic>, <italic>Ankrd55</italic>, <italic>Jazf1</italic>, <italic>Ccnd2</italic> and <italic>Tle1</italic> was downregulated, whereas expression of <italic>Vps26a</italic>, <italic>Thada</italic>, <italic>Bcl11a</italic> and <italic>Bcl2</italic> was upregulated after <italic>Tcf7l2</italic> knockdown (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F5">5</xref>; <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Tables S1 and S2</ext-link>).</p></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>The current report presents a genetic network controlled by TCF7L2 in pancreatic islets, providing a comprehensive view of the molecular mechanisms by which TCF7L2 regulates glucose metabolism. We demonstrate that TCF7L2 plays a central role in coordinating the expression of proinsulin and its subsequent processing to form mature insulin. We also show that TCF7L2 and ISL1 are key regulators of this transcriptional network and provide evidence that they regulate MAFA, PDX1, NEUROD1 and NKX6.1 (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F6">6</xref>). The two prohormone convertases responsible for the processing of proinsulin to mature insulin were also targets of TCF7L2/ISL1 regulation. These functions seem to have been highly conserved during evolution as similar results were obtained in a rat cell line, primary mouse and human islets. In line with a previous report of an overrepresentation of TCF7L2 binding to genes in T2D-associated loci in HCT116 cells (<xref rid="DDU359C47" ref-type="bibr">47</xref>), we find that TCF7L2 regulates several of these genes also in pancreatic islets. Of note, <italic>SLC30A8</italic> (encoding the zinc transporter ZnT8) is a downstream target of TCF7L2/ISL1 regulation. Zinc is important for the formation of insulin crystals (<xref rid="DDU359C48" ref-type="bibr">48</xref>), and a common non-synonymous SNP in the zinc transporter <italic>SLC30A8</italic> has been associated with both T2D (<xref rid="DDU359C40" ref-type="bibr">40</xref>) and reduced proinsulin-to-insulin conversion (<xref rid="DDU359C15" ref-type="bibr">15</xref>). <italic>SLC30A8</italic> has previously been identified as a TCF7L2-target gene in mice (<xref rid="DDU359C29" ref-type="bibr">29</xref>), a finding now replicated in humans. Although the mechanisms by which the variant in <italic>SLC30A8</italic> increases risk of T2D are not clear, recent data suggest that reduction in zinc concentrations in the portal vein after &#x003b2;-cell-specific disruption of <italic>Slc30a8</italic> might influence hepatic insulin clearance (<xref rid="DDU359C49" ref-type="bibr">49</xref>). If confirmed, this would suggest that <italic>TCF7L2</italic> might influence all key steps in (pro)insulin synthesis, processing and clearance.
<fig id="DDU359F6" position="float"><label>Figure&#x000a0;6.</label><caption><p>Schematic figure of how TCF7L2 functions as a master regulator of insulin production and processing. Identified TCF7L2-target genes and the downstream regulatory network responsible for its effect on insulin secretion. In rodents, as well as human pancreatic islets, <italic>ISL1</italic> is a direct target of TCF7L2. ISL1 regulates proinsulin production and processing via regulation of PCSK1, PCSK2, SLC30A8, MAFA, PDX1 and NKX6.1. These multiple targets in key pathways may explain why <italic>TCF7L2</italic> has emerged as the gene showing the strongest association with T2D among common variants. Red arrows: molecular links observed for the first time. Black arrows: known molecular links. Direct arrows: direct molecular links. Dash arrows: indirect molecular links. Blue gene symbols: MODY genes. Purple gene symbols: genes associated with T2D and/or (pro)insulin traits.</p></caption><graphic xlink:href="ddu35906"/></fig></p><p>Transcription of proinsulin in humans is under the control of many glucose responsive TFs that mainly bind a 400 bp conserved region (<xref rid="DDU359C50" ref-type="bibr">50</xref>,<xref rid="DDU359C51" ref-type="bibr">51</xref>). Among the most studied TFs are MAFA, PDX1 and NEUROD1, all shown here to be transcriptional targets of TCF7L2/ISL1 regulation. In support of this, ISL1 regulates <italic>MAFA</italic> expression by directly binding to the <italic>MAFA</italic> promoter (<xref rid="DDU359C52" ref-type="bibr">52</xref>), but its influence on <italic>Pdx1</italic>, <italic>Nkx6.1</italic>, <italic>Pcsk1</italic> and <italic>Pcsk2</italic> expression has not been described to our knowledge. Together with our recent demonstration of direct binding of TCF7L2 to the <italic>Isl1</italic> promoter (<xref rid="DDU359C30" ref-type="bibr">30</xref>), these data indicate that TCF7L2 together with ISL1 forms a master regulatory circuit influencing both proinsulin expression and processing via regulation of <italic>MafA</italic>, <italic>Pdx1</italic>, <italic>Nkx6.1</italic>, <italic>Pcsk1</italic> and <italic>Pcsk2</italic>. As ISL1 also can bind and influence the expression of other pancreatic hormones like glucagon (<xref rid="DDU359C53" ref-type="bibr">53</xref>) and somatostatin (<xref rid="DDU359C54" ref-type="bibr">54</xref>), this indicates that TCF7L2 may also have important regulatory functions in other islet cell types besides the B-cell. Relatively high expression of <italic>TCF7L2</italic> in &#x003b1;-cells has also been reported in sorted human pancreatic islet cells (<xref rid="DDU359C55" ref-type="bibr">55</xref>). A recent study indicated that NEUROD1 regulates the expression of <italic>Ins1</italic> but not <italic>Ins2</italic> in primary mouse &#x003b2; cells (<xref rid="DDU359C56" ref-type="bibr">56</xref>), whereas we observed altered expression of both proinsulin genes and <italic>Nkx6.1</italic> in rat cell line.</p><p>TCF7L2 may also regulate other &#x003b2;-cell functions essential for maintaining GSIS. A perturbation of intracellular [Ca<sup>2+</sup>] was observed in one <italic>Tcf7l2</italic><sup>&#x02212;/&#x02212;</sup> mouse model, but no major effect on the expression of Ca<sup>2+</sup> channels (<xref rid="DDU359C29" ref-type="bibr">29</xref>). Here, we find that although the mRNA levels of several Ca<sup>2+</sup> channels important for GSIS were reduced in <italic>Tcf7l2</italic> silenced cells, no changes of the corresponding proteins were observed either 72 h or 7 days after <italic>Tcf7l2</italic> knockdown. An effect of TCF7L2 on Ca<sup>2+</sup> handling in the B-cell should however not be excluded based upon these data as these proteins may have a very long half-life in the cell. An influence on cell viability and regulation of apoptosis are other well-documented effects of TCF7L2 in pancreatic islets (<xref rid="DDU359C11" ref-type="bibr">11</xref>,<xref rid="DDU359C30" ref-type="bibr">30</xref>,<xref rid="DDU359C57" ref-type="bibr">57</xref>). The T2D-associated SNP rs7903146 has also been associated with pancreatic islet morphology, i.e. with reduced islets density, reduction of islet size and an increased &#x003b1;- to &#x003b2;-cell ratio in risk-genotype carriers (<xref rid="DDU359C31" ref-type="bibr">31</xref>). In the same report, an association between the rs7903146 and GSIS was seen; but not with insulin content per islet equivalent as shown in our study. There may be several explanations for these discrepancies but a large number of high-quality human islets are probably needed to demonstrate a significant reduction in insulin content, as the state of the islets can have a large influence on insulin measurements.</p><p>Some recent reports have questioned the dogma that genetic variants in <italic>TCF7L2</italic> exert its major effect on islets (<xref rid="DDU359C23" ref-type="bibr">23</xref>,<xref rid="DDU359C58" ref-type="bibr">58</xref>). Boj <italic>et al.</italic> recently reported reduced hepatic glucose production in a liver-specific <italic>Tcf7l2</italic> knockout mouse model (<xref rid="DDU359C23" ref-type="bibr">23</xref>). We and others have shown an association between the rs7903146 variant and impaired suppression of hepatic glucose production (<xref rid="DDU359C7" ref-type="bibr">7</xref>,<xref rid="DDU359C59" ref-type="bibr">59</xref>,<xref rid="DDU359C60" ref-type="bibr">60</xref>), but it is not easy to disentangle these effects from the effects of a reduction in insulin secretion (<xref rid="DDU359C61" ref-type="bibr">61</xref>). Surprisingly, they reported no impaired effects on &#x003b2;-cell function in a &#x003b2;-cell-specific <italic>Tcf7l2</italic> knockout mouse (<xref rid="DDU359C23" ref-type="bibr">23</xref>). This finding is in sharp contrast with previous reports showing reduced &#x003b2;-cell mass, a perturbed incretin response and GSIS with reduced insulin expression (<xref rid="DDU359C24" ref-type="bibr">24</xref>,<xref rid="DDU359C27" ref-type="bibr">27</xref>). Although there are no apparent explanations for these discrepant results they could reflect the application of B-cell-specific versus whole-islet knockdown strategies, as <italic>TCF7L2</italic> is also expressed in &#x003b1;-cells (<xref rid="DDU359C55" ref-type="bibr">55</xref>), or a difference between inducible versus congenital knockdown of <italic>TCF7L2</italic>, as Wnt signaling is important for pancreas development (<xref rid="DDU359C62" ref-type="bibr">62</xref>). An alternative explanation is a possible compensatory increased expression of other genes taking over the role of TCF7L2 in the &#x003b2; cells, in support is the reported lack of regulation of well-known TCF7L2-target genes, i.e. <italic>Axin2</italic> and <italic>Sp5</italic> (<xref rid="DDU359C23" ref-type="bibr">23</xref>). <italic>TCF7L2</italic> is expressed in many tissues besides the pancreas and here is no doubt that it has central functions in tissues like the brain (<xref rid="DDU359C58" ref-type="bibr">58</xref>,<xref rid="DDU359C63" ref-type="bibr">63</xref>,<xref rid="DDU359C64" ref-type="bibr">64</xref>), liver (<xref rid="DDU359C23" ref-type="bibr">23</xref>,<xref rid="DDU359C65" ref-type="bibr">65</xref>,<xref rid="DDU359C66" ref-type="bibr">66</xref>), adipose tissue (<xref rid="DDU359C67" ref-type="bibr">67</xref>,<xref rid="DDU359C68" ref-type="bibr">68</xref>) and the gut (<xref rid="DDU359C58" ref-type="bibr">58</xref>,<xref rid="DDU359C69" ref-type="bibr">69</xref>). However, given the central role of insulin for maintenance of normal glucose tolerance it is unlikely that an extrapancreatic mechanism could exert an effect size of that seen for the rs7903146 in <italic>TCF7L2</italic>.</p><p>Interestingly, in human islets we observe a negative association between <italic>TCF7L2</italic> expression and target gene expression in the proinsulin synthesis pathway (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>D), but also find that silencing total expression of <italic>TCF7L2</italic> leads to reduced proinsulin expression (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F2">2</xref>C). Experimental disruption of TCF7L2 activity has previously been associated with perturbed islet function (<xref rid="DDU359C8" ref-type="bibr">8</xref>,<xref rid="DDU359C11" ref-type="bibr">11</xref>,<xref rid="DDU359C24" ref-type="bibr">24</xref>,<xref rid="DDU359C29" ref-type="bibr">29</xref>&#x02013;<xref rid="DDU359C31" ref-type="bibr">31</xref>) but the risk T-allele is suggested to lead to increased expression of <italic>TCF7L2</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>C) (<xref rid="DDU359C7" ref-type="bibr">7</xref>,<xref rid="DDU359C22" ref-type="bibr">22</xref>,<xref rid="DDU359C31" ref-type="bibr">31</xref>,<xref rid="DDU359C32" ref-type="bibr">32</xref>) and perturbed GSIS in human islets (Fig.&#x000a0;<xref ref-type="fig" rid="DDU359F1">1</xref>A) (<xref rid="DDU359C2" ref-type="bibr">2</xref>,<xref rid="DDU359C7" ref-type="bibr">7</xref>&#x02013;<xref rid="DDU359C12" ref-type="bibr">12</xref>,<xref rid="DDU359C31" ref-type="bibr">31</xref>). These seemingly contradictory findings might reflect that total expression of <italic>TCF7L2</italic> does not mirror TCF7L2 activity and rather it is the ratio of activating and inhibiting TCF7L2 isoforms that determine the activity and hence target gene regulation (<xref rid="DDU359C33" ref-type="bibr">33</xref>). The rs7903146 is located near the variable exon 4 (also named 3a), an exon that have particularly high expression in human islets compared with other tissues (<xref rid="DDU359C4" ref-type="bibr">4</xref>). This exon has also been shown to exhibit regulatory properties, inhibiting TCF7L2-target gene expression in different cell lines (<xref rid="DDU359C70" ref-type="bibr">70</xref>,<xref rid="DDU359C71" ref-type="bibr">71</xref>). Loss of exon 4 also promotes hepatic tumorigenicity (<xref rid="DDU359C72" ref-type="bibr">72</xref>). Future experiments would be warranted to investigate if increased expression of exon 4 containing or other isoforms (<xref rid="DDU359C67" ref-type="bibr">67</xref>) of TCF7L2 may propagate the risk of T2D conferred by the T-allele of rs7903146.</p><p>In summary, in rodents as well as human pancreatic islets, <italic>ISL1</italic> is a direct target of TCF7L2 and ISL1, in turn, regulates proinsulin production and processing via regulation of PCSK1, PCSK2, SLC30A8, MAFA, PDX1 and NKX6.1. Furthermore, TCF7L2 might also influence hepatic clearance of insulin via its effect on SLC30A8. Taken together, the current results provide some explanations for the large impact of <italic>TCF7L2</italic> on the pathogenesis of T2D demonstrating that TCF7L2 is a key regulator of (pro)insulin synthesis, processing and possibly clearance.</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4a"><title>RNA sequencing</title><p>Sample preparation was made using Illumina TrueSeq&#x02122; RNA sample preparation kit with 1 &#x000b5;g of high-quality total RNA and was sequenced using a paired-end 101 bp protocol on the HiSeq2000 platform (Illumina). For INS1 cells, reads were aligned using Top Hat 2.0.0(<xref rid="DDU359C73" ref-type="bibr">73</xref>) and Bowtie version: 2.0.0.5 (<xref rid="DDU359C74" ref-type="bibr">74</xref>) to the rat RGSC3.4 genome assembly. For human islet, 66 samples (all non-diabetic) were sequenced. Sequencing reads were aligned to the human reference genome (hg19) with STAR version 2.3.0e (<xref rid="DDU359C75" ref-type="bibr">75</xref>) and counted using HTseq v0.5.4 and edgeR (<xref rid="DDU359C76" ref-type="bibr">76</xref>). The raw sequence reads have been deposited at European Nucleotide Archive (ERA261116) and at GEO (GSE50398) for INS1 and human islets, respectively.</p></sec><sec id="s4b"><title>Real-time QPCR and western blot</title><p>Total RNA was extracted using RNeasy Plus Mini Kit (Qiagen), cDNA was prepared using RevertAid<sup>TM</sup> First Strand cDNA Synthesis Kit (Thermo Scientific). QPCR was performed using TaqMan assays (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S5</ext-link>). mRNA was measured 48 h (INS1 cells) or 24 h (human islets) after silencing. For human islets, dispersed human islet cells in 804G-conditioned medium-coated dishes (<xref rid="DDU359C77" ref-type="bibr">77</xref>) were used. Protein (15&#x02013;80 &#x000b5;g) was separated by SDS&#x02013;PAGE, transferred to nitrocellulose membranes and detection was made using SuperSignalWestFemto Chemiluminescent Substrate (Thermo Scientific). Protein expression was measured 72 h or 7 days after silencing. Antibodies used can be found in <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material, Table S5</ext-link>.</p></sec><sec id="s4c"><title>Statistical analysis</title><p>Statistical analyses were performed in IBM<sup>&#x000ae;</sup> statistics version 21 (IBM Corporation, Armonk, NY, USA). Student's <italic>t</italic>-test was used when two groups were compared and paired <italic>t</italic>-test was used for analysis of GSIS, GSPS and TIRFM data. <italic>P</italic> &#x0003c; 0.05 was regarded as significant and two-tailed <italic>P</italic>-values were calculated. FDR of 5% was used to correct for multiple comparisons. All results are given as mean &#x000b1; SEM unless otherwise stated.</p></sec></sec><sec id="s5"><title>SUPPLEMENTARY MATERIAL</title><p><ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddu359/-/DC1">Supplementary Material is available at <italic>HMG</italic> online</ext-link>.</p></sec><sec id="s6"><title>FUNDING</title><p>This work has been supported through funding from the <funding-source id="cs1" rid="cn1">Swedish Research Council</funding-source>, grants (number <award-id id="cn1" rid="cs1">2007-4037, 2009-2001, 2007-5721, 2008-6589</award-id> and <award-id id="cn2" rid="cs2">2009-1039</award-id>) the <funding-source id="cs2" rid="cn2">Knut and Alice Wallenberg foundation</funding-source> (<award-id id="cn3" rid="cs3">KAW 2009.0243</award-id>), the <funding-source id="cs3" rid="cn3">Wallenberg foundation, the Lundberg foundation</funding-source> (grant nr. <award-id id="cn4" rid="cs4">359</award-id>), the <funding-source id="cs4" rid="cn4">Swedish Diabetes Research Foundation</funding-source> (<award-id id="cn5" rid="cs5">2009-060</award-id>) and the <funding-source id="cs5" rid="cn5">European Commission's Seventh Framework Program</funding-source> fund (the CEED3 consortium, <award-id id="cn6" rid="cs6">Health-2008-223211</award-id>), the <funding-source id="cs6" rid="cn6">UMAS fund, Novo Nordisk Foundation, Magus Bergvall's Foundation, Craafoord Foundation, Tore Nilson's Foundation, the Hjelt Foundation, EFSD/MSD, the United States Public Health Service and by the National Institutes of Health and the Kovler Family Foundation</funding-source>. Funding to pay the Open Access publication charges for this article was provided by Swedish Research Council grants 2009-1039.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplementary Data</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_23_24_6419__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="msword"
xlink:href="supp_ddu359_ddu359supp.docx"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="vnd.ms-excel"
xlink:href="supp_ddu359_ddu359supp_table6.xlsx"/>
</supplementary-material>
</sec>
</body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We give our most sincere thanks to Mar Gonz&#x000e0;les-Porta, Karl Bacos, Jens Lagerstedt, Anna-Maria Veljanovska Ramsay, Ulrika Krus, Jasmina Kravic, Lena Eliasson, Anders Rosengren, Emma Ahlqvist and Peter Osmark and Alex Persson (Lund University) for constructive suggestions and technical assistance. The human islet was provided from the Human Tissue Laboratory at Lund University in collaboration with Olle Korsgren (Uppsala University) and the Nordic Network for Clinical Islet Transplantation.</p><p><italic>Conflict of Interest statement</italic>. None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="DDU359C1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>S.F.</given-names></name><name><surname>Thorleifsson</surname><given-names>G.</given-names></name><name><surname>Reynisdottir</surname><given-names>I.</given-names></name><name><surname>Benediktsson</surname><given-names>R.</given-names></name><name><surname>Manolescu</surname><given-names>A.</given-names></name><name><surname>Sainz</surname><given-names>J.</given-names></name><name><surname>Helgason</surname><given-names>A.</given-names></name><name><surname>Stefansson</surname><given-names>H.</given-names></name><name><surname>Emilsson</surname><given-names>V.</given-names></name><name><surname>Helgadottir</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes</article-title><source>Nat. Genet.</source><year>2006</year><volume>38</volume><fpage>320</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">16415884</pub-id></element-citation></ref><ref id="DDU359C2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R.</given-names></name><name><surname>Gianniny</surname><given-names>L.</given-names></name><name><surname>Burtt</surname><given-names>N.P.</given-names></name><name><surname>Lyssenko</surname><given-names>V.</given-names></name><name><surname>Giuducci</surname><given-names>C.</given-names></name><name><surname>Sjogren</surname><given-names>M.</given-names></name><name><surname>Florez</surname><given-names>J.C.</given-names></name><name><surname>Almgren</surname><given-names>P.</given-names></name><name><surname>Isomaa</surname><given-names>B.</given-names></name><name><surname>Orho-Melander</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2890</fpage><lpage>2895</lpage><pub-id pub-id-type="pmid">17003358</pub-id></element-citation></ref><ref id="DDU359C3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchi</surname><given-names>S.</given-names></name><name><surname>El Achhab</surname><given-names>Y.</given-names></name><name><surname>Choquet</surname><given-names>H.</given-names></name><name><surname>Dina</surname><given-names>C.</given-names></name><name><surname>Krempler</surname><given-names>F.</given-names></name><name><surname>Weitgasser</surname><given-names>R.</given-names></name><name><surname>Nejjari</surname><given-names>C.</given-names></name><name><surname>Patsch</surname><given-names>W.</given-names></name><name><surname>Chikri</surname><given-names>M.</given-names></name><name><surname>Meyre</surname><given-names>D.</given-names></name><etal/></person-group><article-title>TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis</article-title><source>J. Mol. Med. (Berl)</source><year>2007</year><volume>85</volume><fpage>777</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">17476472</pub-id></element-citation></ref><ref id="DDU359C4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osmark</surname><given-names>P.</given-names></name><name><surname>Hansson</surname><given-names>O.</given-names></name><name><surname>Jonsson</surname><given-names>A.</given-names></name><name><surname>Ronn</surname><given-names>T.</given-names></name><name><surname>Groop</surname><given-names>L.</given-names></name><name><surname>Renstrom</surname><given-names>E.</given-names></name></person-group><article-title>Unique splicing pattern of the TCF7L2 gene in human pancreatic islets</article-title><source>Diabetologia</source><year>2009</year><volume>52</volume><fpage>850</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">19247628</pub-id></element-citation></ref><ref id="DDU359C5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>J.C.</given-names></name><name><surname>Jablonski</surname><given-names>K.A.</given-names></name><name><surname>Bayley</surname><given-names>N.</given-names></name><name><surname>Pollin</surname><given-names>T.I.</given-names></name><name><surname>de Bakker</surname><given-names>P.I.</given-names></name><name><surname>Shuldiner</surname><given-names>A.R.</given-names></name><name><surname>Knowler</surname><given-names>W.C.</given-names></name><name><surname>Nathan</surname><given-names>D.M.</given-names></name><name><surname>Altshuler</surname><given-names>D.</given-names></name></person-group><article-title>TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program</article-title><source>N. Engl. J. Med.</source><year>2006</year><volume>355</volume><fpage>241</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">16855264</pub-id></element-citation></ref><ref id="DDU359C6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>J.C.</given-names></name></person-group><article-title>Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?</article-title><source>Diabetologia</source><year>2008</year><volume>51</volume><fpage>1100</fpage><lpage>1110</lpage><pub-id pub-id-type="pmid">18504548</pub-id></element-citation></ref><ref id="DDU359C7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyssenko</surname><given-names>V.</given-names></name><name><surname>Lupi</surname><given-names>R.</given-names></name><name><surname>Marchetti</surname><given-names>P.</given-names></name><name><surname>Del Guerra</surname><given-names>S.</given-names></name><name><surname>Orho-Melander</surname><given-names>M.</given-names></name><name><surname>Almgren</surname><given-names>P.</given-names></name><name><surname>Sjogren</surname><given-names>M.</given-names></name><name><surname>Ling</surname><given-names>C.</given-names></name><name><surname>Eriksson</surname><given-names>K.F.</given-names></name><name><surname>Lethagen</surname><given-names>A.L.</given-names></name><etal/></person-group><article-title>Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes</article-title><source>J. Clin. Invest.</source><year>2007</year><volume>117</volume><fpage>2155</fpage><lpage>2163</lpage><pub-id pub-id-type="pmid">17671651</pub-id></element-citation></ref><ref id="DDU359C8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>L.</given-names></name><name><surname>Matveyenko</surname><given-names>A.V.</given-names></name><name><surname>Kerr-Conte</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>J.H.</given-names></name><name><surname>McIntosh</surname><given-names>C.H.</given-names></name><name><surname>Maedler</surname><given-names>K.</given-names></name></person-group><article-title>Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function</article-title><source>Hum. Mol. Genet.</source><year>2009</year><volume>18</volume><fpage>2388</fpage><lpage>2399</lpage><pub-id pub-id-type="pmid">19386626</pub-id></element-citation></ref><ref id="DDU359C9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosengren</surname><given-names>A.H.</given-names></name><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Mahdi</surname><given-names>T.</given-names></name><name><surname>Andersson</surname><given-names>S.A.</given-names></name><name><surname>Travers</surname><given-names>M.E.</given-names></name><name><surname>Shigeto</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>E.</given-names></name><name><surname>Almgren</surname><given-names>P.</given-names></name><name><surname>Ladenvall</surname><given-names>C.</given-names></name><name><surname>Axelsson</surname><given-names>A.S.</given-names></name><etal/></person-group><article-title>Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes</article-title><source>Diabetes</source><year>2012</year><volume>61</volume><fpage>1726</fpage><lpage>1733</lpage><pub-id pub-id-type="pmid">22492527</pub-id></element-citation></ref><ref id="DDU359C10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y.C.</given-names></name><name><surname>Chiu</surname><given-names>Y.F.</given-names></name><name><surname>Ho</surname><given-names>L.L.</given-names></name><name><surname>Ting</surname><given-names>C.T.</given-names></name><name><surname>Shih</surname><given-names>K.C.</given-names></name><name><surname>Curb</surname><given-names>J.D.</given-names></name><name><surname>Chen</surname><given-names>Y.D.</given-names></name><name><surname>Li</surname><given-names>H.Y.</given-names></name><name><surname>Chuang</surname><given-names>L.M.</given-names></name></person-group><article-title>TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance</article-title><source>J. Mol. Med. (Berl)</source><year>2010</year><volume>88</volume><fpage>183</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">19806338</pub-id></element-citation></ref><ref id="DDU359C11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>L.</given-names></name><name><surname>Sauter</surname><given-names>N.S.</given-names></name><name><surname>Schulthess</surname><given-names>F.T.</given-names></name><name><surname>Matveyenko</surname><given-names>A.V.</given-names></name><name><surname>Oberholzer</surname><given-names>J.</given-names></name><name><surname>Maedler</surname><given-names>K.</given-names></name></person-group><article-title>Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><fpage>645</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">18071026</pub-id></element-citation></ref><ref id="DDU359C12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loder</surname><given-names>M.K.</given-names></name><name><surname>da Silva Xavier</surname><given-names>G.</given-names></name><name><surname>McDonald</surname><given-names>A.</given-names></name><name><surname>Rutter</surname><given-names>G.A.</given-names></name></person-group><article-title>TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells</article-title><source>Biochem. Soc. Trans.</source><year>2008</year><volume>36</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">18481957</pub-id></element-citation></ref><ref id="DDU359C13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlgren</surname><given-names>A.</given-names></name><name><surname>Zethelius</surname><given-names>B.</given-names></name><name><surname>Jensevik</surname><given-names>K.</given-names></name><name><surname>Syvanen</surname><given-names>A.C.</given-names></name><name><surname>Berne</surname><given-names>C.</given-names></name></person-group><article-title>Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><fpage>1852</fpage><lpage>1857</lpage><pub-id pub-id-type="pmid">17618413</pub-id></element-citation></ref><ref id="DDU359C14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Sanchez</surname><given-names>J.L.</given-names></name><name><surname>Martinez-Larrad</surname><given-names>M.T.</given-names></name><name><surname>Zabena</surname><given-names>C.</given-names></name><name><surname>Perez-Barba</surname><given-names>M.</given-names></name><name><surname>Serrano-Rios</surname><given-names>M.</given-names></name></person-group><article-title>Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population</article-title><source>Diabetologia</source><year>2008</year><volume>51</volume><fpage>1993</fpage><lpage>1997</lpage><pub-id pub-id-type="pmid">18712344</pub-id></element-citation></ref><ref id="DDU359C15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchhoff</surname><given-names>K.</given-names></name><name><surname>Machicao</surname><given-names>F.</given-names></name><name><surname>Haupt</surname><given-names>A.</given-names></name><name><surname>Schafer</surname><given-names>S.A.</given-names></name><name><surname>Tschritter</surname><given-names>O.</given-names></name><name><surname>Staiger</surname><given-names>H.</given-names></name><name><surname>Stefan</surname><given-names>N.</given-names></name><name><surname>Haring</surname><given-names>H.U.</given-names></name><name><surname>Fritsche</surname><given-names>A.</given-names></name></person-group><article-title>Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion</article-title><source>Diabetologia</source><year>2008</year><volume>51</volume><fpage>597</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">18264689</pub-id></element-citation></ref><ref id="DDU359C16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loos</surname><given-names>R.J.</given-names></name><name><surname>Franks</surname><given-names>P.W.</given-names></name><name><surname>Francis</surname><given-names>R.W.</given-names></name><name><surname>Barroso</surname><given-names>I.</given-names></name><name><surname>Gribble</surname><given-names>F.M.</given-names></name><name><surname>Savage</surname><given-names>D.B.</given-names></name><name><surname>Ong</surname><given-names>K.K.</given-names></name><name><surname>O'Rahilly</surname><given-names>S.</given-names></name><name><surname>Wareham</surname><given-names>N.J.</given-names></name></person-group><article-title>TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><fpage>1943</fpage><lpage>1947</lpage><pub-id pub-id-type="pmid">17416797</pub-id></element-citation></ref><ref id="DDU359C17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaffery</surname><given-names>J.M.</given-names></name><name><surname>Jablonski</surname><given-names>K.A.</given-names></name><name><surname>Franks</surname><given-names>P.W.</given-names></name><name><surname>Dagogo-Jack</surname><given-names>S.</given-names></name><name><surname>Wing</surname><given-names>R.R.</given-names></name><name><surname>Knowler</surname><given-names>W.C.</given-names></name><name><surname>Delahanty</surname><given-names>L.</given-names></name><name><surname>Dabelea</surname><given-names>D.</given-names></name><name><surname>Hamman</surname><given-names>R.</given-names></name><name><surname>Shuldiner</surname><given-names>A.R.</given-names></name><etal/></person-group><article-title>TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e21518</fpage><pub-id pub-id-type="pmid">21814547</pub-id></element-citation></ref><ref id="DDU359C18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silbernagel</surname><given-names>G.</given-names></name><name><surname>Renner</surname><given-names>W.</given-names></name><name><surname>Grammer</surname><given-names>T.B.</given-names></name><name><surname>Hugl</surname><given-names>S.R.</given-names></name><name><surname>Bertram</surname><given-names>J.</given-names></name><name><surname>Kleber</surname><given-names>M.E.</given-names></name><name><surname>Hoffmann</surname><given-names>M.M.</given-names></name><name><surname>Winkelmann</surname><given-names>B.R.</given-names></name><name><surname>Marz</surname><given-names>W.</given-names></name><name><surname>Boehm</surname><given-names>B.O.</given-names></name></person-group><article-title>Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1</article-title><source>Diabetes Metab. Res. Rev.</source><year>2011</year><volume>27</volume><fpage>499</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">21384500</pub-id></element-citation></ref><ref id="DDU359C19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolerman</surname><given-names>E.S.</given-names></name><name><surname>Manning</surname><given-names>A.K.</given-names></name><name><surname>McAteer</surname><given-names>J.B.</given-names></name><name><surname>Fox</surname><given-names>C.S.</given-names></name><name><surname>Dupuis</surname><given-names>J.</given-names></name><name><surname>Meigs</surname><given-names>J.B.</given-names></name><name><surname>Florez</surname><given-names>J.C.</given-names></name></person-group><article-title>TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study</article-title><source>Diabetologia</source><year>2009</year><volume>52</volume><fpage>614</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">19183934</pub-id></element-citation></ref><ref id="DDU359C20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strawbridge</surname><given-names>R.J.</given-names></name><name><surname>Dupuis</surname><given-names>J.</given-names></name><name><surname>Prokopenko</surname><given-names>I.</given-names></name><name><surname>Barker</surname><given-names>A.</given-names></name><name><surname>Ahlqvist</surname><given-names>E.</given-names></name><name><surname>Rybin</surname><given-names>D.</given-names></name><name><surname>Petrie</surname><given-names>J.R.</given-names></name><name><surname>Travers</surname><given-names>M.E.</given-names></name><name><surname>Bouatia-Naji</surname><given-names>N.</given-names></name><name><surname>Dimas</surname><given-names>A.S.</given-names></name><etal/></person-group><article-title>Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes</article-title><source>Diabetes</source><year>2011</year><volume>60</volume><fpage>2624</fpage><lpage>2634</lpage><pub-id pub-id-type="pmid">21873549</pub-id></element-citation></ref><ref id="DDU359C21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>J.</given-names></name><name><surname>Langenberg</surname><given-names>C.</given-names></name><name><surname>Prokopenko</surname><given-names>I.</given-names></name><name><surname>Saxena</surname><given-names>R.</given-names></name><name><surname>Soranzo</surname><given-names>N.</given-names></name><name><surname>Jackson</surname><given-names>A.U.</given-names></name><name><surname>Wheeler</surname><given-names>E.</given-names></name><name><surname>Glazer</surname><given-names>N.L.</given-names></name><name><surname>Bouatia-Naji</surname><given-names>N.</given-names></name><name><surname>Gloyn</surname><given-names>A.L.</given-names></name><etal/></person-group><article-title>New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><fpage>105</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">20081858</pub-id></element-citation></ref><ref id="DDU359C22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaulton</surname><given-names>K.J.</given-names></name><name><surname>Nammo</surname><given-names>T.</given-names></name><name><surname>Pasquali</surname><given-names>L.</given-names></name><name><surname>Simon</surname><given-names>J.M.</given-names></name><name><surname>Giresi</surname><given-names>P.G.</given-names></name><name><surname>Fogarty</surname><given-names>M.P.</given-names></name><name><surname>Panhuis</surname><given-names>T.M.</given-names></name><name><surname>Mieczkowski</surname><given-names>P.</given-names></name><name><surname>Secchi</surname><given-names>A.</given-names></name><name><surname>Bosco</surname><given-names>D.</given-names></name><etal/></person-group><article-title>A map of open chromatin in human pancreatic islets</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">20118932</pub-id></element-citation></ref><ref id="DDU359C23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boj</surname><given-names>S.F.</given-names></name><name><surname>van Es</surname><given-names>J.H.</given-names></name><name><surname>Huch</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>V.S.</given-names></name><name><surname>Jose</surname><given-names>A.</given-names></name><name><surname>Hatzis</surname><given-names>P.</given-names></name><name><surname>Mokry</surname><given-names>M.</given-names></name><name><surname>Haegebarth</surname><given-names>A.</given-names></name><name><surname>van den Born</surname><given-names>M.</given-names></name><name><surname>Chambon</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand</article-title><source>Cell</source><year>2012</year><volume>151</volume><fpage>1595</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">23260145</pub-id></element-citation></ref><ref id="DDU359C24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Xavier</surname><given-names>G.</given-names></name><name><surname>Mondragon</surname><given-names>A.</given-names></name><name><surname>Sun</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>McGinty</surname><given-names>J.A.</given-names></name><name><surname>French</surname><given-names>P.M.</given-names></name><name><surname>Rutter</surname><given-names>G.A.</given-names></name></person-group><article-title>Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice</article-title><source>Diabetologia</source><year>2012</year><volume>55</volume><fpage>2667</fpage><lpage>2676</lpage><pub-id pub-id-type="pmid">22717537</pub-id></element-citation></ref><ref id="DDU359C25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korinek</surname><given-names>V.</given-names></name><name><surname>Barker</surname><given-names>N.</given-names></name><name><surname>Moerer</surname><given-names>P.</given-names></name><name><surname>van Donselaar</surname><given-names>E.</given-names></name><name><surname>Huls</surname><given-names>G.</given-names></name><name><surname>Peters</surname><given-names>P.J.</given-names></name><name><surname>Clevers</surname><given-names>H.</given-names></name></person-group><article-title>Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4</article-title><source>Nat. Genet.</source><year>1998</year><volume>19</volume><fpage>379</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">9697701</pub-id></element-citation></ref><ref id="DDU359C26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savic</surname><given-names>D.</given-names></name><name><surname>Ye</surname><given-names>H.</given-names></name><name><surname>Aneas</surname><given-names>I.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Bell</surname><given-names>G.I.</given-names></name><name><surname>Nobrega</surname><given-names>M.A.</given-names></name></person-group><article-title>Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism</article-title><source>Genome Res.</source><year>2011</year><volume>21</volume><fpage>1417</fpage><lpage>1425</lpage><pub-id pub-id-type="pmid">21673050</pub-id></element-citation></ref><ref id="DDU359C27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamoto</surname><given-names>I.</given-names></name><name><surname>Kubota</surname><given-names>N.</given-names></name><name><surname>Nakaya</surname><given-names>K.</given-names></name><name><surname>Kumagai</surname><given-names>K.</given-names></name><name><surname>Hashimoto</surname><given-names>S.</given-names></name><name><surname>Kubota</surname><given-names>T.</given-names></name><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Kajiwara</surname><given-names>E.</given-names></name><name><surname>Katsuyama</surname><given-names>H.</given-names></name><name><surname>Obata</surname><given-names>A.</given-names></name><etal/></person-group><article-title>TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass</article-title><source>Diabetologia</source><year>2013</year><volume>57</volume><fpage>542</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">24317852</pub-id></element-citation></ref><ref id="DDU359C28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Shu</surname><given-names>Y.</given-names></name></person-group><article-title>Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice</article-title><source>Int. J. Biol. Sci.</source><year>2012</year><volume>8</volume><fpage>791</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">22719219</pub-id></element-citation></ref><ref id="DDU359C29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Xavier</surname><given-names>G.</given-names></name><name><surname>Loder</surname><given-names>M.K.</given-names></name><name><surname>McDonald</surname><given-names>A.</given-names></name><name><surname>Tarasov</surname><given-names>A.I.</given-names></name><name><surname>Carzaniga</surname><given-names>R.</given-names></name><name><surname>Kronenberger</surname><given-names>K.</given-names></name><name><surname>Barg</surname><given-names>S.</given-names></name><name><surname>Rutter</surname><given-names>G.A.</given-names></name></person-group><article-title>TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells</article-title><source>Diabetes</source><year>2009</year><volume>58</volume><fpage>894</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">19168596</pub-id></element-citation></ref><ref id="DDU359C30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>E.</given-names></name><name><surname>Berggreen</surname><given-names>C.</given-names></name><name><surname>Jing</surname><given-names>X.</given-names></name><name><surname>Osmark</surname><given-names>P.</given-names></name><name><surname>Lang</surname><given-names>S.</given-names></name><name><surname>Cilio</surname><given-names>C.M.</given-names></name><name><surname>Goransson</surname><given-names>O.</given-names></name><name><surname>Groop</surname><given-names>L.</given-names></name><name><surname>Renstrom</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway</article-title><source>Hum. Mol. Genet.</source><year>2012</year><volume>21</volume><fpage>196</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">21965303</pub-id></element-citation></ref><ref id="DDU359C31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bacquer</surname><given-names>O.</given-names></name><name><surname>Kerr-Conte</surname><given-names>J.</given-names></name><name><surname>Gargani</surname><given-names>S.</given-names></name><name><surname>Delalleau</surname><given-names>N.</given-names></name><name><surname>Huyvaert</surname><given-names>M.</given-names></name><name><surname>Gmyr</surname><given-names>V.</given-names></name><name><surname>Froguel</surname><given-names>P.</given-names></name><name><surname>Neve</surname><given-names>B.</given-names></name><name><surname>Pattou</surname><given-names>F.</given-names></name></person-group><article-title>TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals</article-title><source>Diabetologia</source><year>2012</year><volume>55</volume><fpage>2677</fpage><lpage>2681</lpage><pub-id pub-id-type="pmid">22911383</pub-id></element-citation></ref><ref id="DDU359C32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stitzel</surname><given-names>M.L.</given-names></name><name><surname>Sethupathy</surname><given-names>P.</given-names></name><name><surname>Pearson</surname><given-names>D.S.</given-names></name><name><surname>Chines</surname><given-names>P.S.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Erdos</surname><given-names>M.R.</given-names></name><name><surname>Welch</surname><given-names>R.</given-names></name><name><surname>Parker</surname><given-names>S.C.</given-names></name><name><surname>Boyle</surname><given-names>A.P.</given-names></name><name><surname>Scott</surname><given-names>L.J.</given-names></name><etal/></person-group><article-title>Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci</article-title><source>Cell Metab.</source><year>2010</year><volume>12</volume><fpage>443</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">21035756</pub-id></element-citation></ref><ref id="DDU359C33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>O.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Renstrom</surname><given-names>E.</given-names></name><name><surname>Osmark</surname><given-names>P.</given-names></name></person-group><article-title>Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes</article-title><source>Curr. Diab. Rep.</source><year>2010</year><volume>10</volume><fpage>444</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">20878273</pub-id></element-citation></ref><ref id="DDU359C34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamid</surname><given-names>Y.H.</given-names></name><name><surname>Urhammer</surname><given-names>S.A.</given-names></name><name><surname>Jensen</surname><given-names>D.P.</given-names></name><name><surname>Glumer</surname><given-names>C.</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K.</given-names></name><name><surname>Jorgensen</surname><given-names>T.</given-names></name><name><surname>Hansen</surname><given-names>T.</given-names></name><name><surname>Pedersen</surname><given-names>O.</given-names></name></person-group><article-title>Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>3342</fpage><lpage>3345</lpage><pub-id pub-id-type="pmid">15561970</pub-id></element-citation></ref><ref id="DDU359C35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>L.</given-names></name><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Hu</surname><given-names>F.B.</given-names></name></person-group><article-title>Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women</article-title><source>. <italic>Diabetes</italic></source><year>2007</year><volume>56</volume><fpage>3075</fpage><lpage>3081</lpage><pub-id pub-id-type="pmid">17898129</pub-id></element-citation></ref><ref id="DDU359C36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>Y.S.</given-names></name><name><surname>Chen</surname><given-names>C.H.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Ong</surname><given-names>R.T.</given-names></name><name><surname>Sim</surname><given-names>X.</given-names></name><name><surname>Takeuchi</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Go</surname><given-names>M.J.</given-names></name><name><surname>Yamauchi</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians</article-title><source>Nat. Genet.</source><year>2012</year><volume>44</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">22158537</pub-id></element-citation></ref><ref id="DDU359C37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kooner</surname><given-names>J.S.</given-names></name><name><surname>Saleheen</surname><given-names>D.</given-names></name><name><surname>Sim</surname><given-names>X.</given-names></name><name><surname>Sehmi</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Frossard</surname><given-names>P.</given-names></name><name><surname>Been</surname><given-names>L.F.</given-names></name><name><surname>Chia</surname><given-names>K.S.</given-names></name><name><surname>Dimas</surname><given-names>A.S.</given-names></name><name><surname>Hassanali</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci</article-title><source>Nat. Genet.</source><year>2011</year><volume>43</volume><fpage>984</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">21874001</pub-id></element-citation></ref><ref id="DDU359C38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R.</given-names></name><name><surname>Voight</surname><given-names>B.F.</given-names></name><name><surname>Lyssenko</surname><given-names>V.</given-names></name><name><surname>Burtt</surname><given-names>N.P.</given-names></name><name><surname>de Bakker</surname><given-names>P.I.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Roix</surname><given-names>J.J.</given-names></name><name><surname>Kathiresan</surname><given-names>S.</given-names></name><name><surname>Hirschhorn</surname><given-names>J.N.</given-names></name><name><surname>Daly</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">17463246</pub-id></element-citation></ref><ref id="DDU359C39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>L.J.</given-names></name><name><surname>Mohlke</surname><given-names>K.L.</given-names></name><name><surname>Bonnycastle</surname><given-names>L.L.</given-names></name><name><surname>Willer</surname><given-names>C.J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Duren</surname><given-names>W.L.</given-names></name><name><surname>Erdos</surname><given-names>M.R.</given-names></name><name><surname>Stringham</surname><given-names>H.M.</given-names></name><name><surname>Chines</surname><given-names>P.S.</given-names></name><name><surname>Jackson</surname><given-names>A.U.</given-names></name><etal/></person-group><article-title>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1341</fpage><lpage>1345</lpage><pub-id pub-id-type="pmid">17463248</pub-id></element-citation></ref><ref id="DDU359C40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sladek</surname><given-names>R.</given-names></name><name><surname>Rocheleau</surname><given-names>G.</given-names></name><name><surname>Rung</surname><given-names>J.</given-names></name><name><surname>Dina</surname><given-names>C.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Serre</surname><given-names>D.</given-names></name><name><surname>Boutin</surname><given-names>P.</given-names></name><name><surname>Vincent</surname><given-names>D.</given-names></name><name><surname>Belisle</surname><given-names>A.</given-names></name><name><surname>Hadjadj</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A genome-wide association study identifies novel risk loci for type 2 diabetes</article-title><source>Nature</source><year>2007</year><volume>445</volume><fpage>881</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">17293876</pub-id></element-citation></ref><ref id="DDU359C41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voight</surname><given-names>B.F.</given-names></name><name><surname>Scott</surname><given-names>L.J.</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V.</given-names></name><name><surname>Morris</surname><given-names>A.P.</given-names></name><name><surname>Dina</surname><given-names>C.</given-names></name><name><surname>Welch</surname><given-names>R.P.</given-names></name><name><surname>Zeggini</surname><given-names>E.</given-names></name><name><surname>Huth</surname><given-names>C.</given-names></name><name><surname>Aulchenko</surname><given-names>Y.S.</given-names></name><name><surname>Thorleifsson</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><fpage>579</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">20581827</pub-id></element-citation></ref><ref id="DDU359C42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeggini</surname><given-names>E.</given-names></name><name><surname>Weedon</surname><given-names>M.N.</given-names></name><name><surname>Lindgren</surname><given-names>C.M.</given-names></name><name><surname>Frayling</surname><given-names>T.M.</given-names></name><name><surname>Elliott</surname><given-names>K.S.</given-names></name><name><surname>Lango</surname><given-names>H.</given-names></name><name><surname>Timpson</surname><given-names>N.J.</given-names></name><name><surname>Perry</surname><given-names>J.R.</given-names></name><name><surname>Rayner</surname><given-names>N.W.</given-names></name><name><surname>Freathy</surname><given-names>R.M.</given-names></name><etal/></person-group><article-title>Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1336</fpage><lpage>1341</lpage><pub-id pub-id-type="pmid">17463249</pub-id></element-citation></ref><ref id="DDU359C43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>M.B.</given-names></name><name><surname>Schon</surname><given-names>E.</given-names></name><name><surname>Henderson</surname><given-names>A.</given-names></name><name><surname>Karathanasis</surname><given-names>S.K.</given-names></name><name><surname>Cate</surname><given-names>R.</given-names></name><name><surname>Zeitlin</surname><given-names>S.</given-names></name><name><surname>Chirgwin</surname><given-names>J.</given-names></name><name><surname>Efstratiadis</surname><given-names>A.</given-names></name></person-group><article-title>RNA-mediated gene duplication: the rat preproinsulin I gene is a functional retroposon</article-title><source>Mol. Cell. Biol.</source><year>1985</year><volume>5</volume><fpage>2090</fpage><lpage>2103</lpage><pub-id pub-id-type="pmid">2427930</pub-id></element-citation></ref><ref id="DDU359C44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Miguel-Yanes</surname><given-names>J.M.</given-names></name><name><surname>Shrader</surname><given-names>P.</given-names></name><name><surname>Pencina</surname><given-names>M.J.</given-names></name><name><surname>Fox</surname><given-names>C.S.</given-names></name><name><surname>Manning</surname><given-names>A.K.</given-names></name><name><surname>Grant</surname><given-names>R.W.</given-names></name><name><surname>Dupuis</surname><given-names>J.</given-names></name><name><surname>Florez</surname><given-names>J.C.</given-names></name><name><surname>D'Agostino</surname><given-names>R.B.</given-names><suffix>Sr</suffix></name><name><surname>Cupples</surname><given-names>L.A.</given-names></name><etal/></person-group><article-title>Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">20889853</pub-id></element-citation></ref><ref id="DDU359C45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>A.P.</given-names></name><name><surname>Voight</surname><given-names>B.F.</given-names></name><name><surname>Teslovich</surname><given-names>T.M.</given-names></name><name><surname>Ferreira</surname><given-names>T.</given-names></name><name><surname>Segre</surname><given-names>A.V.</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V.</given-names></name><name><surname>Strawbridge</surname><given-names>R.J.</given-names></name><name><surname>Khan</surname><given-names>H.</given-names></name><name><surname>Grallert</surname><given-names>H.</given-names></name><name><surname>Mahajan</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes</article-title><source>Nat. Genet.</source><year>2012</year><volume>44</volume><fpage>981</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">22885922</pub-id></element-citation></ref><ref id="DDU359C46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R.</given-names></name><name><surname>Elbers</surname><given-names>C.C.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Peter</surname><given-names>I.</given-names></name><name><surname>Gaunt</surname><given-names>T.R.</given-names></name><name><surname>Mega</surname><given-names>J.L.</given-names></name><name><surname>Lanktree</surname><given-names>M.B.</given-names></name><name><surname>Tare</surname><given-names>A.</given-names></name><name><surname>Castillo</surname><given-names>B.A.</given-names></name><name><surname>Li</surname><given-names>Y.R.</given-names></name><etal/></person-group><article-title>Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci</article-title><source>Am. J. Hum. Genet.</source><year>2012</year><volume>90</volume><fpage>410</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">22325160</pub-id></element-citation></ref><ref id="DDU359C47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Schug</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Kaestner</surname><given-names>K.H.</given-names></name><name><surname>Grant</surname><given-names>S.F.</given-names></name></person-group><article-title>Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo</article-title><source>Diabetologia</source><year>2010</year><volume>53</volume><fpage>2340</fpage><lpage>2346</lpage><pub-id pub-id-type="pmid">20640398</pub-id></element-citation></ref><ref id="DDU359C48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>D.A.</given-names></name></person-group><article-title>Crystalline insulin</article-title><source>Biochem J</source><year>1934</year><volume>28</volume><fpage>1592</fpage><lpage>1602</lpage><comment>1591</comment><pub-id pub-id-type="pmid">16745551</pub-id></element-citation></ref><ref id="DDU359C49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamaki</surname><given-names>M.</given-names></name><name><surname>Fujitani</surname><given-names>Y.</given-names></name><name><surname>Hara</surname><given-names>A.</given-names></name><name><surname>Uchida</surname><given-names>T.</given-names></name><name><surname>Tamura</surname><given-names>Y.</given-names></name><name><surname>Takeno</surname><given-names>K.</given-names></name><name><surname>Kawaguchi</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name><name><surname>Ogihara</surname><given-names>T.</given-names></name><name><surname>Fukunaka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance</article-title><source>J. Clin. Invest.</source><year>2013</year><volume>123</volume><fpage>4513</fpage><lpage>4524</lpage><pub-id pub-id-type="pmid">24051378</pub-id></element-citation></ref><ref id="DDU359C50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Z.</given-names></name><name><surname>Gilbert</surname><given-names>E.R.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name></person-group><article-title>Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes</article-title><source>Curr. Diabetes Rev.</source><year>2013</year><volume>9</volume><fpage>25</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">22974359</pub-id></element-citation></ref><ref id="DDU359C51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>C.W.</given-names></name><name><surname>Docherty</surname><given-names>K.</given-names></name></person-group><article-title>Comparative analysis of insulin gene promoters: implications for diabetes research</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>3201</fpage><lpage>3213</lpage><pub-id pub-id-type="pmid">17130462</pub-id></element-citation></ref><ref id="DDU359C52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>A.</given-names></name><name><surname>Hunter</surname><given-names>C.S.</given-names></name><name><surname>Murray</surname><given-names>J.</given-names></name><name><surname>Noble</surname><given-names>D.</given-names></name><name><surname>Cai</surname><given-names>C.L.</given-names></name><name><surname>Evans</surname><given-names>S.M.</given-names></name><name><surname>Stein</surname><given-names>R.</given-names></name><name><surname>May</surname><given-names>C.L.</given-names></name></person-group><article-title>Islet-1 is required for the maturation, proliferation, and survival of the endocrine pancreas</article-title><source>Diabetes</source><year>2009</year><volume>58</volume><fpage>2059</fpage><lpage>2069</lpage><pub-id pub-id-type="pmid">19502415</pub-id></element-citation></ref><ref id="DDU359C53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Drucker</surname><given-names>D.J.</given-names></name></person-group><article-title>The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>12646</fpage><lpage>12652</lpage><pub-id pub-id-type="pmid">7759514</pub-id></element-citation></ref><ref id="DDU359C54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>J.</given-names></name><name><surname>Serup</surname><given-names>P.</given-names></name><name><surname>Gonzalez</surname><given-names>G.</given-names></name><name><surname>Edlund</surname><given-names>T.</given-names></name><name><surname>Montminy</surname><given-names>M.</given-names></name></person-group><article-title>The LIM family transcription factor Isl-1 requires cAMP response element binding protein to promote somatostatin expression in pancreatic islet cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1992</year><volume>89</volume><fpage>6247</fpage><lpage>6251</lpage><pub-id pub-id-type="pmid">1352885</pub-id></element-citation></ref><ref id="DDU359C55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>C.L.</given-names></name><name><surname>Marchetti</surname><given-names>P.</given-names></name><name><surname>Purrello</surname><given-names>F.</given-names></name><name><surname>Piro</surname><given-names>S.</given-names></name><name><surname>Bugliani</surname><given-names>M.</given-names></name><name><surname>Bosco</surname><given-names>D.</given-names></name><name><surname>de Koning</surname><given-names>E.J.</given-names></name><name><surname>Engelse</surname><given-names>M.A.</given-names></name><name><surname>Kerr-Conte</surname><given-names>J.</given-names></name><name><surname>Pattou</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><fpage>e11053</fpage><pub-id pub-id-type="pmid">20548773</pub-id></element-citation></ref><ref id="DDU359C56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>C.</given-names></name><name><surname>Stein</surname><given-names>G.H.</given-names></name><name><surname>Pan</surname><given-names>N.</given-names></name><name><surname>Goebbels</surname><given-names>S.</given-names></name><name><surname>Hornberg</surname><given-names>H.</given-names></name><name><surname>Nave</surname><given-names>K.A.</given-names></name><name><surname>Herrera</surname><given-names>P.</given-names></name><name><surname>White</surname><given-names>P.</given-names></name><name><surname>Kaestner</surname><given-names>K.H.</given-names></name><name><surname>Sussel</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Pancreatic beta cells require NeuroD to achieve and maintain functional maturity</article-title><source>Cell Metab.</source><year>2010</year><volume>11</volume><fpage>298</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">20374962</pub-id></element-citation></ref><ref id="DDU359C57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bacquer</surname><given-names>O.</given-names></name><name><surname>Shu</surname><given-names>L.</given-names></name><name><surname>Marchand</surname><given-names>M.</given-names></name><name><surname>Neve</surname><given-names>B.</given-names></name><name><surname>Paroni</surname><given-names>F.</given-names></name><name><surname>Kerr Conte</surname><given-names>J.</given-names></name><name><surname>Pattou</surname><given-names>F.</given-names></name><name><surname>Froguel</surname><given-names>P.</given-names></name><name><surname>Maedler</surname><given-names>K.</given-names></name></person-group><article-title>TCF7L2 splice variants have distinct effects on beta-cell turnover and function</article-title><source>Hum. Mol. Genet.</source><year>2011</year><volume>20</volume><fpage>1906</fpage><lpage>1915</lpage><pub-id pub-id-type="pmid">21357677</pub-id></element-citation></ref><ref id="DDU359C58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Chiang</surname><given-names>Y.T.</given-names></name><name><surname>Ip</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Columbus</surname><given-names>J.</given-names></name><name><surname>Belsham</surname><given-names>D.D.</given-names></name><name><surname>Irwin</surname><given-names>D.M.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis</article-title><source>Diabetes</source><year>2013</year><volume>62</volume><fpage>789</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">22966074</pub-id></element-citation></ref><ref id="DDU359C59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilgaard</surname><given-names>K.</given-names></name><name><surname>Jensen</surname><given-names>C.B.</given-names></name><name><surname>Schou</surname><given-names>J.H.</given-names></name><name><surname>Lyssenko</surname><given-names>V.</given-names></name><name><surname>Wegner</surname><given-names>L.</given-names></name><name><surname>Brons</surname><given-names>C.</given-names></name><name><surname>Vilsboll</surname><given-names>T.</given-names></name><name><surname>Hansen</surname><given-names>T.</given-names></name><name><surname>Madsbad</surname><given-names>S.</given-names></name><name><surname>Holst</surname><given-names>J.J.</given-names></name><etal/></person-group><article-title>The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men</article-title><source>Diabetologia</source><year>2009</year><volume>52</volume><fpage>1298</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">19288077</pub-id></element-citation></ref><ref id="DDU359C60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegner</surname><given-names>L.</given-names></name><name><surname>Hussain</surname><given-names>M.S.</given-names></name><name><surname>Pilgaard</surname><given-names>K.</given-names></name><name><surname>Hansen</surname><given-names>T.</given-names></name><name><surname>Pedersen</surname><given-names>O.</given-names></name><name><surname>Vaag</surname><given-names>A.</given-names></name><name><surname>Poulsen</surname><given-names>P.</given-names></name></person-group><article-title>Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2008</year><volume>93</volume><fpage>4013</fpage><lpage>4019</lpage><pub-id pub-id-type="pmid">18611970</pub-id></element-citation></ref><ref id="DDU359C61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faerch</surname><given-names>K.</given-names></name><name><surname>Pilgaard</surname><given-names>K.</given-names></name><name><surname>Knop</surname><given-names>F.K.</given-names></name><name><surname>Hansen</surname><given-names>T.</given-names></name><name><surname>Pedersen</surname><given-names>O.</given-names></name><name><surname>Jorgensen</surname><given-names>T.</given-names></name><name><surname>Holst</surname><given-names>J.J.</given-names></name></person-group><article-title>Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele</article-title><source>Diabetes Obes. Metab.</source><year>2013</year><volume>15</volume><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">22862926</pub-id></element-citation></ref><ref id="DDU359C62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murtaugh</surname><given-names>L.C.</given-names></name></person-group><article-title>The what, where, when and how of Wnt/beta-catenin signaling in pancreas development</article-title><source>Organogenesis</source><year>2008</year><volume>4</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">18953422</pub-id></element-citation></ref><ref id="DDU359C63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>C.E.</given-names></name><name><surname>Elias</surname><given-names>C.F.</given-names></name><name><surname>Elmquist</surname><given-names>J.K.</given-names></name></person-group><article-title>Expression of the diabetes-associated gene TCF7L2 in adult mouse brain</article-title><source>J. Comp. Neurol.</source><year>2009</year><volume>517</volume><fpage>925</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">19845015</pub-id></element-citation></ref><ref id="DDU359C64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savic</surname><given-names>D.</given-names></name><name><surname>Distler</surname><given-names>M.G.</given-names></name><name><surname>Sokoloff</surname><given-names>G.</given-names></name><name><surname>Shanahan</surname><given-names>N.A.</given-names></name><name><surname>Dulawa</surname><given-names>S.C.</given-names></name><name><surname>Palmer</surname><given-names>A.A.</given-names></name><name><surname>Nobrega</surname><given-names>M.A.</given-names></name></person-group><article-title>Modulation ofTcf7l2 expression alters behavior in mice</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e26897</fpage><pub-id pub-id-type="pmid">22046400</pub-id></element-citation></ref><ref id="DDU359C65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>W.</given-names></name><name><surname>Shao</surname><given-names>W.</given-names></name><name><surname>Chiang</surname><given-names>Y.T.</given-names></name><name><surname>Jin</surname><given-names>T.</given-names></name></person-group><article-title>The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis</article-title><source>Am. J. Physiol. Endocrinol. Metab.</source><year>2012</year><volume>303</volume><fpage>E1166</fpage><lpage>E1176</lpage><pub-id pub-id-type="pmid">22967502</pub-id></element-citation></ref><ref id="DDU359C66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>K.J.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.S.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name><name><surname>Choi</surname><given-names>C.S.</given-names></name><name><surname>Koo</surname><given-names>S.H.</given-names></name></person-group><article-title>TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver</article-title><source>PLoS Genet.</source><year>2012</year><volume>8</volume><fpage>e1002986</fpage><pub-id pub-id-type="pmid">23028378</pub-id></element-citation></ref><ref id="DDU359C67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>A.K.</given-names></name><name><surname>Das</surname><given-names>S.K.</given-names></name><name><surname>Baldini</surname><given-names>G.</given-names></name><name><surname>Chu</surname><given-names>W.S.</given-names></name><name><surname>Sharma</surname><given-names>N.K.</given-names></name><name><surname>Hackney</surname><given-names>O.G.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Grant</surname><given-names>S.F.</given-names></name><name><surname>Elbein</surname><given-names>S.C.</given-names></name></person-group><article-title>Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2010</year><volume>95</volume><fpage>1450</fpage><lpage>1457</lpage><pub-id pub-id-type="pmid">20097709</pub-id></element-citation></ref><ref id="DDU359C68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokunina-Olsson</surname><given-names>L.</given-names></name><name><surname>Kaplan</surname><given-names>L.M.</given-names></name><name><surname>Schadt</surname><given-names>E.E.</given-names></name><name><surname>Collins</surname><given-names>F.S.</given-names></name></person-group><article-title>Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><fpage>e7231</fpage><pub-id pub-id-type="pmid">19789636</pub-id></element-citation></ref><ref id="DDU359C69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminska</surname><given-names>D.</given-names></name><name><surname>Kuulasmaa</surname><given-names>T.</given-names></name><name><surname>Venesmaa</surname><given-names>S.</given-names></name><name><surname>Kakela</surname><given-names>P.</given-names></name><name><surname>Vaittinen</surname><given-names>M.</given-names></name><name><surname>Pulkkinen</surname><given-names>L.</given-names></name><name><surname>Paakkonen</surname><given-names>M.</given-names></name><name><surname>Gylling</surname><given-names>H.</given-names></name><name><surname>Laakso</surname><given-names>M.</given-names></name><name><surname>Pihlajamaki</surname><given-names>J.</given-names></name></person-group><article-title>Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism</article-title><source>Diabetes</source><year>2012</year><volume>61</volume><fpage>2807</fpage><lpage>2813</lpage><pub-id pub-id-type="pmid">23086040</pub-id></element-citation></ref><ref id="DDU359C70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weise</surname><given-names>A.</given-names></name><name><surname>Bruser</surname><given-names>K.</given-names></name><name><surname>Elfert</surname><given-names>S.</given-names></name><name><surname>Wallmen</surname><given-names>B.</given-names></name><name><surname>Wittel</surname><given-names>Y.</given-names></name><name><surname>Wohrle</surname><given-names>S.</given-names></name><name><surname>Hecht</surname><given-names>A.</given-names></name></person-group><article-title>Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets</article-title><source>Nucleic Acids Res.</source><year>2010</year><volume>38</volume><fpage>1964</fpage><lpage>1981</lpage><pub-id pub-id-type="pmid">20044351</pub-id></element-citation></ref><ref id="DDU359C71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsedensodnom</surname><given-names>O.</given-names></name><name><surname>Koga</surname><given-names>H.</given-names></name><name><surname>Rosenberg</surname><given-names>S.A.</given-names></name><name><surname>Nambotin</surname><given-names>S.B.</given-names></name><name><surname>Carroll</surname><given-names>J.J.</given-names></name><name><surname>Wands</surname><given-names>J.R.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name></person-group><article-title>Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells</article-title><source>Exp. Cell Res.</source><year>2011</year><volume>317</volume><fpage>920</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">21256126</pub-id></element-citation></ref><ref id="DDU359C72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomimaru</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>C.Q.</given-names></name><name><surname>Nambotin</surname><given-names>S.B.</given-names></name><name><surname>Yan</surname><given-names>T.</given-names></name><name><surname>Wands</surname><given-names>J.R.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name></person-group><article-title>Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity</article-title><source>Liver Int.</source><year>2013</year><volume>33</volume><fpage>1536</fpage><lpage>1548</lpage><pub-id pub-id-type="pmid">23648141</pub-id></element-citation></ref><ref id="DDU359C73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Pertea</surname><given-names>G.</given-names></name><name><surname>Trapnell</surname><given-names>C.</given-names></name><name><surname>Pimentel</surname><given-names>H.</given-names></name><name><surname>Kelley</surname><given-names>R.</given-names></name><name><surname>Salzberg</surname><given-names>S.L.</given-names></name></person-group><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome Biol.</source><year>2013</year><volume>14</volume><fpage>R36</fpage><pub-id pub-id-type="pmid">23618408</pub-id></element-citation></ref><ref id="DDU359C74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B.</given-names></name><name><surname>Salzberg</surname><given-names>S.L.</given-names></name></person-group><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nat. Methods</source><year>2012</year><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="DDU359C75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>C.A.</given-names></name><name><surname>Schlesinger</surname><given-names>F.</given-names></name><name><surname>Drenkow</surname><given-names>J.</given-names></name><name><surname>Zaleski</surname><given-names>C.</given-names></name><name><surname>Jha</surname><given-names>S.</given-names></name><name><surname>Batut</surname><given-names>P.</given-names></name><name><surname>Chaisson</surname><given-names>M.</given-names></name><name><surname>Gingeras</surname><given-names>T.R.</given-names></name></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="DDU359C76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M.D.</given-names></name><name><surname>McCarthy</surname><given-names>D.J.</given-names></name><name><surname>Smyth</surname><given-names>G.K.</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="DDU359C77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammar</surname><given-names>E.</given-names></name><name><surname>Parnaud</surname><given-names>G.</given-names></name><name><surname>Bosco</surname><given-names>D.</given-names></name><name><surname>Perriraz</surname><given-names>N.</given-names></name><name><surname>Maedler</surname><given-names>K.</given-names></name><name><surname>Donath</surname><given-names>M.</given-names></name><name><surname>Rouiller</surname><given-names>D.G.</given-names></name><name><surname>Halban</surname><given-names>P.A.</given-names></name></person-group><article-title>Extracellular matrix protects pancreatic beta-cells against apoptosis: role of short- and long-term signaling pathways</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>2034</fpage><lpage>2041</lpage><pub-id pub-id-type="pmid">15277383</pub-id></element-citation></ref></ref-list></back></article>